Stockwinners Market Radar for September 17, 2018 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

CAAP

Hot Stocks

20:43 EDT Corporacion America Airport reports Augst traffic up 5.8% - Total passenger traffic in August 2018 increased by 5.8% y/y, primarily reflecting growths of 6.6% in Argentina, 18.5% in Armenia, 4.3% in Italy and 2.3% in Brazil. In Argentina, passenger traffic increased 6.6% y/y, mainly driven by a 15.1% growth in domestic traffic, partially offset by declines of 7.1% and 10.9% in international and transit passengers, respectively, reflecting more challenging macro conditions. Domestic traffic benefited from the incorporation of several new frequencies to existing routes, both domestic and international, that were added over the past 12 months. Several new airlines have announced they will start operating during the next months: Norwegian airlines plans to open seven domestic routes, Chilean low-cost company JetSmart expects to open international routes from Santiago de Chile and La Serena to three provinces in Argentina and LASA Airlines anticipates it will inaugurate domestic and international routes, operating from Neuquen Airport. In Armenia, passenger traffic at Zvartnots Airport increased during this month mainly due to the increase in international passengers coming from the US during summer season. This increase was partially offset by a decrease in passengers coming from Russia and other European destinations. In Shirak Airport, passenger traffic benefited from the opening of new routes to new destinations in Russia. In Italy, passenger traffic increased 4.3% YoY. Pisa Airport continued to reflect a considerable increase in passengers travelling to Russia, and at Florence Airport, the new route to Lisbon, Portugal, opened last June, continued to perform very well. In Brazil, passenger traffic at Brasilia Airport increased 3.1% YoY, driven by the addition of new frequencies to existing routes in several domestic destinations by Gol, Latam and Azul. Moreover, Gol announced the opening of a new international route, that is expected to open in December, with six weekly flights between Brasilia, Brazil and Buenos Aires, Argentina. In Uruguay, passenger traffic declined 6.0% mainly due to currency depreciation in neighboring countries Brazil and Argentina, which resulted in a decrease in passengers.
SAFM

Hot Stocks

19:08 EDT Sanderson Farms says no known serious injuries, loss of life from hurricane - Sanderson Farms reported that the company continues its assessment of damage to its North Carolina assets caused by Hurricane Florence. The company said that it has still received no report of serious injuries or loss of life among its employees and growers. As earlier reported, the company experienced no significant damage to either of its North Carolina processing facilities, feed mill or two hatcheries. The company's facilities located in the affected area maintained generator power until permanent electrical service was restored. The company resumed operations at its feed mill located in Kinston, North Carolina, this morning. However, many roadways in North Carolina remain impassable, serious flooding continues, and local streams and rivers are expected to crest later this week. The company will resume operations at its Kinston, North Carolina, processing plant on Tuesday, and at its St. Pauls processing plant by the end of this week, once it is safe for employees to navigate roads and highways. The company continues its assessment of damage to independent farms and losses to its live inventories. Out of 880 broiler houses in North Carolina, 60 have flooded. Another six houses experienced damage and will be unable to house broilers until repairs are made. In addition to the affected broiler houses, four breeder houses out of a total of 92 in North Carolina flooded. At this point, none of the company's 33 pullet houses have reported serious damage. As a result of these losses, the company estimates that approximately 1.7 million head of broiler chickens out of an average live inventory of approximately 20 million head, ranging in age from six days to sixty-two days, were destroyed as a result of flooding. In addition, approximately thirty farms, housing approximately 211,000 chickens per farm, in the Lumberton, North Carolina, area are isolated by flood waters and the company is unable to reach those farms with feed trucks. Losses of live inventory could escalate if the company does not regain access to those farms. The company does not believe the loss of housing capacity will affect its ongoing operations, as it can shorten layouts and take other temporary measures to compensate for these losses.
FATE

Hot Stocks

19:01 EDT Fate Therapeutics to partner with ONO Pharma on Car-T cell immunotherapy - Fate Therapeutics announced that it has entered into a collaboration with ONO Pharmaceutical Co., Ltd. for the joint development and commercialization of two off-the-shelf CAR-T cell product candidates. Using Fate Therapeutics' proprietary induced pluripotent stem cell product platform, the two CAR T-cell collaboration candidates will each be derived from a clonal master iPSC line engineered to completely eliminate endogenous TCR expression, insert a chimeric antigen receptor into the TRAC locus and incorporate other anti-tumor functionality. This transformative approach enables the cost-effective production of cell-based cancer immunotherapies that are uniformly engineered, extensively characterized and homogeneous in composition, and can be consistently and repeatedly mass produced and delivered to patients in an off-the-shelf manner. Under the terms of the strategic option agreement, Fate Therapeutics and ONO will jointly advance each iPSC-derived CAR-T cell collaboration candidate to a pre-defined preclinical milestone. The first iPSC-derived CAR T-cell candidate targets an antigen expressed on certain lymphoblastic leukemias, and Fate Therapeutics retains global responsibility for development and commercialization with ONO having an option to assume responsibilities in Asia. The second candidate targets a novel antigen identified by ONO expressed on certain solid tumors, with ONO having an option to assume global responsibility for further development and commercialization and Fate Therapeutics retaining the right to co-develop and co-commercialize the candidate in the United States and Europe. For both collaboration candidates, Fate Therapeutics retains manufacturing responsibilities on a global basis.
BMRN

Hot Stocks

19:01 EDT BioMarin exec David sells 12,000 common shares - In a regulatory filing, BioMarin Pharmaceutical's executive VP and General Counsel George Eric Davis disclosed the sale of 12,000 common shares of the company at a price of $99.57 per share.
NXEO...

Hot Stocks

18:50 EDT Fly Intel: After Hours Movers - HIGHER: Nexeo Solutions (NXEO) up 14.9% after being acquired by Univar... ImmunoGen (IMGN) up 3.3% after being initiated at Buy at Guggenheim... Ensco (ESV) up 2.0% after being initiated at Buy at BTIG... Transocean (RIG) up 1.8% after being initiated at Buy at BTIG... Array BioPharma (ARRY) up 1.5% after being initiated at Buy at Guggenheim... Bluebird Bio (BLUE) up 1.4% after being initiated at Buy at Guggenheim... Symantec (SYMC) up 0.5% after updating its Board under advisement of Starboard... Walmart (WMT) up 0.3% after being initiated at Outperform at BMO Capital. DOWN AFTER EARNINGS: Oracle (ORCL) down 4.0%... FedEx (FDX) down 2.3%. ALSO LOWER: Argenx (ARGX) down 3.5% after equity offering... Splunk (SPLK) down 0.9% after offering convertible notes.
BHP

Hot Stocks

18:34 EDT BHP chairman: 'cautious' on short term outlook, but 'long term view positive' - Comments from BHP's Annual Report. Reference Link
SVU

Hot Stocks

18:30 EDT Supervalu to sell 19 of 36 Shop 'n Save stores to Schnuck Markets - Supervalu announced it has entered into a definitive agreement to sell 19 of its 36 Shop 'n Save grocery stores, primarily located in the St. Louis, Mo. area, to Schnuck Markets, Inc. The transaction is planned to occur with a staggered close process that is currently expected to finish by late October 2018, subject to customary closing conditions. As part of the acquisition, Supervalu and Schnucks will also enter into an agreement for Supervalu to serve as the primary supplier for nine of Schnucks' existing stores located across northern Illinois, Iowa and Wisconsin. As part of the acquired stores, Schnucks will acquire 15 in-store pharmacy locations and one stand-alone pharmacy which will remain open, and prescription files at 10 other Shop 'n Save pharmacy locations that will be transferred to other Schnucks pharmacies in the area. Customers of the Shop 'n Save pharmacies that will close will receive detailed information on the transfer of their pharmacy files by mail within the next several days, and information will also be available at each pharmacy. Schnucks will also acquire four of Shop 'n Save's seven fuel centers. A complete list of stores, pharmacies and fuel centers to be sold to Schnucks under this agreement, along with a list of correlating pharmacies where prescription files will be transferred, is included in the addendum to this press release.
HHC

Hot Stocks

18:18 EDT Pershing Square establishes 10b5-1 plan for portion of Howard Hughes stake - Pershing Square has established a non-discretionary trading plan to sell a portion of its common stock in The Howard Hughes Corporation over a period of time that will end no later than November 30, 2018, in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934. None of the other Pershing Square funds are participating in the program as their HHC position is appropriately sized. PSLP is selling shares in HHC for portfolio management purposes only. These sales do not represent a change in Pershing Square's view that HHC remains an attractive long-term investment. Pershing Square continues to believe that HHC is substantially undervalued at its current share price. The 10b5-1 program provides that PSLP will sell up to 875,000 shares at prices at or above $125 per share, and will be limited to a maximum of 9.8% of each trading day's volume. Assuming the 10b5-1 program is completed on or before its end date of November 30, 2018, it is expected that in total, the Pershing Square funds will beneficially own 3.1% of HHC. In addition, Pershing Square Holdings, Ltd., Pershing Square International, Ltd. and Pershing Square II L.P. will continue to own total return swaps on 4,229,933M shares, or 9.8% of HHC. Assuming the 10b5-1 program is completed, the Pershing Square funds will then have total economic exposure, including common stock and total return swaps, of 12.9% of HHC. In accordance with Section 16 of the 1934 Act, within two days of each day's execution under the 10b5-1 program, Pershing Square will disclose that day's trading in a Form 4 filing with the SEC. The initial Form 4 filing, in addition to potential sales under this program, will disclose the sale of a portion of a total return swap held by Pershing Square International Ltd., which was not part of the 10b5-1 program.
AWK

Hot Stocks

18:16 EDT Missouri American Water plans pipeline upgrade on West Florissant Avenue - Missouri American Water said it is beginning work on a project to replace approximately 4,300 feet of water main in North Saint Louis County in the municipalities of Ferguson and Dellwood, Mo., on West Florissant Ave. from Canfield Drive to Chambers Road. Starting this week, the company will install 20-inch ductile iron water main in the area in an effort to improve service reliability and prevent water main breaks. Crews will generally be working weekdays between 7 a.m. and 7 p.m. with some night time connections. Traffic restrictions will be in place during construction and motorists are urged to give themselves extra time and exercise caution when traveling through the work zone. The company expects to complete the new main installation, testing and disinfection, and connecting customers' service lines to the new main by December 1, weather permitting. Final paving restoration is expected to be completed by the end of 2018, weather permitting.
FB

Hot Stocks

17:47 EDT Instagram announces new updates to its app - Earlier today, Instagram, a unit of Facebook, said in a blog post: "Since expanding shopping on Instagram to more countries in March, businesses all over the world have been able to connect with customers in a fresh, immersive way on Instagram-giving them more opportunities to showcase their products while allowing consumers to explore the brands they love. In June, we announced that we were bringing shopping to Instagram Stories through a test with a small number of businesses. Today, we are giving all businesses approved for shopping on Instagram access to Shopping in Stories and launching the test of a Shopping Channel in Explore...To give people a faster way to shop on Instagram Stories, we are enabling businesses to add product stickers in stories, so they can easily integrate products into their stories content. Instagram Stories has seen rapid growth in adoption among consumers, with more than 400 million accounts using the feature daily. People love stories for its immersive, full-screen format, and one-third of the most-viewed stories are from businesses. Now, businesses that are approved to use the shopping feature can meet more shoppers where they are in a meaningful way." Reference Link
ORCL

Hot Stocks

17:40 EDT Oracle says expects operating cash flow to increase - Says software maintenance fees are growing.
MPVD

Hot Stocks

17:34 EDT Mountain Province Diamonds says more kimberlite found in exploration program - Mountain Province Diamonds provides an update on the exploration program currently under way in the immediate vicinity of the Gahcho Kue mine. The most recent drilling has now identified additional kimberlite in the corridor between 5034 and Tuzo, with true intercepts up to 72 meters in thickness. The Curie target has also been confirmed to have kimberlite intercepts up to 52 meters with the full extent of all the additional kimberlite still to be determined. The detailed exploration program has focused on three objectives; drill test for extensions to the Hearne kimberlite between the north and south lobes, drill test the corridor between 5034 and Tuzo, particularly around the North Pipe kimberlite, and drill test the Curie ground gravity target located between the Tesla and Tuzo kimberlites. Additional kimberlite breccia between the north and south lobes at Hearne was previously confirmed, extending vertically from 40 metres depth from the surface and to at least as deep as 220 metres depth. Drill testing of the corridor between 5034 and Tuzo has focused on the zone between the 5034 pipe and the North pipe and an area immediately northeast of the North pipe. Drilling has confirmed kimberlitic material between the north lobe of 5034 and the North Pipe, as well as in the corridor extending northeast of the North Pipe towards Tuzo. This new kimberlitic material extends vertically from 248 meters to 350 meters depth. At the Curie target, kimberlite was intersected at a vertical depth of only 18 meters, with the deepest intercept at 119 meters depth. The Curie kimberlite lies within the proposed open pit mine plan for the Tuzo kimberlite, and midway between Tuzo and the Tesla kimberlite.
ORCL

Hot Stocks

17:32 EDT Oracle's Hurd says expects President Thomas Kurian to return
ORCL

Hot Stocks

17:21 EDT Oracle says SaaS, PaaS pipeline at 'record level'
ORCL

Hot Stocks

17:16 EDT Oracle's Ellsion says sees 'rapid' cloud market share gain
HII

Hot Stocks

17:15 EDT Huntington Ingalls awarded $104.3M U.S. Navy contract modification - Huntington Ingalls is awarded a $104,260,102 cost-plus-fixed-fee modification to previously awarded contract to exercise options for engineering, technical, design, configuration management, integrated logistics support, database management, research and development, modernization and industrial support for nuclear submarines. Work will be performed in Newport News, Virginia, and is expected to be completed by September 2019.
TRIB

Hot Stocks

17:14 EDT Stonehill Capital reports 7.9% passive stake in Trinity Biotech
FDX

Hot Stocks

17:13 EDT FedEx CFO says higher FY19 EPS guidance due to strong economy - Also attributes raised guidance to revenue management improvements.
FDX

Hot Stocks

17:10 EDT FedEx CFO says Q1 earnings benefited by 50c from tax reform
UNP

Hot Stocks

17:09 EDT Union Pacific says 'not currently meeting customer expectations' - Union Pacific announced its Unified Plan 2020, a new operating plan that implements Precision Scheduled Railroading principles. Unified Plan 2020 will launch Oct. 1 and will be rolled out in phases across the entire Union Pacific rail network. "We are not currently meeting customer expectations," said Lance Fritz, Union Pacific's chairman, president and CEO. "Unified Plan 2020 is our path forward to secure our place as the industry leader in safety, service and financial performance." Precision Scheduled Railroading is operational at other large North American railroads, driving improved service reliability for customers, increased operating efficiency and reduced network complexity. Key principles being incorporated into Union Pacific's Unified Plan 2020 include: Shifting the focus of operations from moving trains to moving cars. Minimizing car dwell, car classification events and locomotive power requirements. Utilizing general-purpose trains by blending existing train services. Balancing train movements to improve the utilization of crews and rail assets. Unified Plan 2020 is being developed in conjunction with employees closest to the work, including in the field, incorporating their experience and expertise. Union Pacific will communicate thoroughly with customers in advance of making changes to existing rail service. The plan will first be implemented on Union Pacific's eastern North/South corridor, creating more streamlined operations between Wisconsin and Texas. Further rollout will occur in phases, with initial implementation across the entire rail network expected by 2020.
FDX

Hot Stocks

17:09 EDT FedEx EVP says current tariffs involve 'small portion' of current China volume - Says "difficult to predict tariff implementation". Sees "uncertainty around China trade tariffs not helping". Forecasting another record "peak season" ahead of the holidays.
UNP

Hot Stocks

17:07 EDT Union Pacific says "not currently meeting customer expectations" - Union Pacific announced its Unified Plan 2020, a new operating plan that implements Precision Scheduled Railroading principles. Unified Plan 2020 will launch Oct. 1 and will be rolled out in phases across the entire Union Pacific rail network. "We are not currently meeting customer expectations," said Lance Fritz, Union Pacific's chairman, president and CEO. "Unified Plan 2020 is our path forward to secure our place as the industry leader in safety, service and financial performance." Precision Scheduled Railroading is operational at other large North American railroads, driving improved service reliability for customers, increased operating efficiency and reduced network complexity. Key principles being incorporated into Union Pacific's Unified Plan 2020 include:Shifting the focus of operations from moving trains to moving cars. Minimizing car dwell, car classification events and locomotive power requirements.Utilizing general-purpose trains by blending existing train services. Balancing train movements to improve the utilization of crews and rail assets. Unified Plan 2020 is being developed in conjunction with employees closest to the work, including in the field, incorporating their experience and expertise. Union Pacific will communicate thoroughly with customers in advance of making changes to existing rail service.The plan will first be implemented on Union Pacific's eastern North/South corridor, creating more streamlined operations between Wisconsin and Texas. Further rollout will occur in phases, with initial implementation across the entire rail network expected by 2020.
FDX

Hot Stocks

17:05 EDT FedEx COO says 'making very good progress on integration of TNT'
FDX

Hot Stocks

17:04 EDT FedEx CEO says 'very optimistic about prospects for growth' - Comments from the FedEx Q1 earnings call.
ORCL

Hot Stocks

17:04 EDT Oracle says total cloud revenue grew in all regions in Q1 - Comments from Q1 earnings conference call.
M FB

Hot Stocks

17:03 EDT Macy's highlights technology to enhance omnichannel, partners with Facebook - Macy's (M) announced that the company is highlighting advanced technology to enhance the omnichannel customer experience. Across the enterprise, new features are being introduced to make the Macy's customer journey more convenient, efficient and fun. The features include both virtual reality and augmented reality furniture and beauty experiences that enable customers to discover product and make more informed buying decisions. The company has also made technological enhancements to several non-customer facing features, including the Beauty Playground training program and RFID that will enable colleagues to offer customers a better in-store shopping experience. The company also announced that it will be partnering with Facebook (FB), which will bring in nearly 150 e-commerce brands to The Market @ Macy's across nine stores this holiday season. "Macy's is focused on providing customers with fresh experiences, and we are always looking for new ways to engage our customers in store, online and via our mobile app," said Hal Lawton, president of Macy's. "Our technology enhancements are practical applications that will engage our customers while also driving sales. The investments we are making behind the scenes will enable our colleagues to give our customers the best shopping experience possible. We're also thrilled to be partnering with Facebook to bring new brands into our retail as a service concept, The Market @ Macy's."
OSIR

Hot Stocks

17:01 EDT Osiris to launch GrafixPL PRIME on October 1st - Osiris Therapeutics announces that GrafixPL PRIME, a human placental membrane that can be stored at ambient temperatures, launches for sale on October 1, 2018. The structural matrix, growth factors, and cell viability of GrafixPL PRIME is equivalent to those of Grafix, a cryopreserved placental membrane, but without the constraints of ultra-low temperature storage. GrafixPL PRIME is processed using Prestige LyotechnologySM, which is Osiris's preservation technique for ambient storage of living tissues. GrafixPL PRIME is flexible and conforming and designed as a wound cover/barrier for application directly to hard-to-treat acute and chronic wounds, including but not limited to diabetic foot ulcers, venous leg ulcers and thermal burns.
IDT

Hot Stocks

17:01 EDT IDT subsidiary net2phone acquires Versature - net2phone, a global provider of unified communications services and subsidiary of IDT Corporation, announced that it has acquired Versature, a rapidly growing SaaS-based business communications solutions and hosted VoIP provider serving the Canadian market. Post-acquisition, Versature plans to accelerate its expansion in Canada through investment in the partner and direct channels, recruitment of additional top talent and continued development of innovative call, voice-centric, and unified communications technology solutions. net2phone's UCaaS and Versature revenues combined in the three months ended July 31, 2018 aggregated to over $5M. Adding Versature's revenues to net2phone's strong organic growth would have boosted net2phone's fourth quarter fiscal 2018 UCaaS generated revenue by approximately 65% over the year-ago quarter.
NJR

Hot Stocks

16:57 EDT New Jersey Natural Gas gets approval to expand energy efficiency programs - New Jersey Natural Gas received approval from the New Jersey Board of Public Utilities to significantly expand its energy-efficiency programs available through The SAVEGREEN Project to help customers better understand and manage their energy usage, reduce emissions and save money. NJNG is authorized to invest $135M over the next three years to provide customized energy solutions to assist residential, public entities, such as schools, and small commercial customers save money on their energy bills. Beginning in January 2019, NJNG will roll out new and expanded programs for the residential and commercial markets, with programs and features available for low- to moderate-income customers and public entities, to help eliminate barriers to energy efficiency and make the benefits more accessible.
FDX

Hot Stocks

16:49 EDT FedEx falls over 2% afterhours following Q1 earnings miss
UNH

Hot Stocks

16:48 EDT UnitedHealth's Burke sells 10,000 common shares - In a regulatory filing, UnitedHealth director Richard T. Burke disclosed the sale of 10,000 common shares of the company at a price of $264.9027 per share.
PRQR

Hot Stocks

16:47 EDT RTW Investments reports 5.05% passive stake in ProQR Therapeutics
TEX

Hot Stocks

16:46 EDT Terex VP Kevin Barr sells almost 12K shares of company stock - Terex VP Kevin Barr disclosed in a filing that he had sold 11,937 shares of company stock at an average price of $38.43 per share on September 13. The total transaction value of the sale was $458,739.
APU

Hot Stocks

16:43 EDT AmeriGas CEO Jerry Sheridan to leave company, Hugh Gallagher to succeed - AmeriGas Propane, the general partner of AmeriGas Partners, L.P., announced that Jerry Sheridan has elected to leave the position of President and CEO and Hugh Gallagher, currently AmeriGas Vice President, Finance and CFO, has been appointed to the President and CEO position, effective September 18. Sheridan has also resigned as a director of the General Partner but will remain an employee of AmeriGas until January 2019 to assist with the transition.
NXEO

Hot Stocks

16:35 EDT Nexeo Solutions trading resumes
ACER

Hot Stocks

16:34 EDT Vivo Opportunity reports 5.3% passive stake in Acer Therapeutics
ROG FORM

Hot Stocks

16:34 EDT Rogers Corporation appoints Michael Ludwig CFO - Rogers Corporation (ROG) announced that Michael Ludwig has been appointed to serve as the company's new SVP, CFO and Treasurer effective September 17. Ludwig brings more than 30 years of financial and accounting experience at public and private companies. He most recently served as the Senior Vice President and Chief Financial Officer of FormFactor (FORM)
NSRGY

Hot Stocks

16:32 EDT Nestle to sell Gerber Life to Western & Southern for $1.55B in cash - Nestle announced that it agreed to sell the Gerber Life Insurance Company, to Western & Southern Financial Group for $1.55B in cash. The deal allows Western & Southern Financial Group to market insurance products under the Gerber Life brand. The transaction does not include Nestle's Gerber Products business, a household brand in baby food and baby care, which Nestle will continue to develop. The agreement follows Nestle's announcement in February 2018 that it was exploring strategic options for the Gerber Life business. The transaction is expected to close in late 2018 or early 2019, following the completion of customary regulatory approvals and closing conditions.
KBR COP

Hot Stocks

16:32 EDT KBR, ConocoPhillips partner on low-cost, mid-scale LNG solutions - KBR (KBR) announced that it is pursuing a new phase of joint development with ConocoPhillips LNG Licensing (COP) to provide low-cost and expedited mid-scale LNG solutions for the marketplace. The companies will leverage their extensive expertise in LNG to jointly develop a standardized LNG train that will provide mid-scale LNG capacity for both greenfield and brownfield expansions seeking an off-the-shelf solution to reduce costs and shorten schedules for LNG facility installations. KBR and ConocoPhillips have agreed to complete a front-end engineering and design quality reference design for a mid-scale capacity LNG train suitable for a wide range of feed gas and ambient temperature conditions. The integrated design approach, utilizing ConocoPhillips' proven Optimized Cascade process technology and constructed with integrated modularized construction, is expected to be available for new LNG projects starting in 2019.
MKL

Hot Stocks

16:31 EDT Markel to acquire majority interest in Brahmin, terms not disclosed - Markel Corporation and Brahmin announced that they have entered into a definitive agreement for Markel to acquire a majority interest in Brahmin. The transaction is subject to customary closing conditions and is expected to close in the fourth quarter of 2018. Additional terms were not disclosed. Brahmin is a creator of fashion leather handbags with significant wholesale distribution and a rapidly growing direct-to-consumer business.
FDX

Hot Stocks

16:19 EDT FedEx says Q1 earnings impacted by investment in staff following tax cuts - CFO Alan Graf said: ""As expected, the quarter's results were affected by our decision to invest in our team members following the passage of the Tax Cuts and Jobs Act. We remain committed to increasing earnings, margins, cash flows and returns this year."
COLD

Hot Stocks

16:18 EDT Americold Realty Trust names Jay Harron CIO - Americold Realty Trust announced two new additions to its leadership team. Jay Harron has joined Americold as its Chief Investment Officer. Harron is responsible for the identification, assessment, negotiation, closing, and integration of all acquisitions, mergers and strategic partnerships. Scott Henderson has joined Americold as SVP, Capital Markets, Treasury and Investor Relations. Henderson serves as the Treasurer and is responsible for debt originations and the overall liquidity of the company.
ORCL

Hot Stocks

16:18 EDT Oracle down 4.4% to $47.01 after Q1 results
MRCY

Hot Stocks

16:17 EDT Mercury Systems receives $20.5M integrated subsystem order from US Navy - Mercury Systems announced that it received a $20.5M follow-on order against a previously announced $152M 5-year sole source basic ordering agreement to deliver integrated subsystems to the U.S. Navy in support of both Navy and Air Force training environments. The order was received in the company's fiscal 2018 fourth quarter and is expected to be shipped over the next several quarters. In total, Mercury received orders of $28.9M in the company's fiscal 2018 fourth quarter against this BOA, with follow-on orders anticipated to continue through the life of the agreement. "We are honored to support this critical military program with our SWaP-optimized subsystems that reliably operate in harsh and hostile environments," said Brian Perry, President, Mercury Defense Systems. "The U.S. Navy and Air Force can confidently select Mercury Systems to ensure the warfighter gains confidence in their ability to be prepared for their role in the battlespace against sophisticated threats."
AYR

Hot Stocks

16:17 EDT Aircastle announces retirement of Chief Commercial Officer Kriedberg in 2020 - Aircastle announced that Michael Kriedberg, the company's Chief Commercial Officer, intends to retire on January 1, 2020. Kriedberg will remain with Aircastle as Chief Commercial Officer until a new commercial leader has been identified and has transitioned into the role. Aircastle will immediately commence a search for his successor.
EVA

Hot Stocks

16:16 EDT Enviva reports 'minimal' damage from Hurricane Florence - Enviva Partners reported that its facilities have incurred only minor damage from Hurricane Florence. The Partnership undertook substantial preparation in advance of Hurricane Florence's landfall to keep employees safe and minimize disruption, including proactively idling operations at its production facility in Sampson County, North Carolina and its deep-water marine terminal in the North Carolina State Ports Authority's Port of Wilmington. Based on initial assessments, the Sampson Plant and Wilmington Terminal have not incurred significant wind or water damage. The Sampson Plant has restarted operations and the Partnership believes its Wilmington Terminal will be able to begin receiving pellets later this week, subject to approval from the NCSPA and other relevant authorities to reopen the Port of Wilmington. With challenges in the NCSPA's Port of Wilmington and the surrounding region due to flooding and residual effects of the storm, the Partnership expects modest impacts to its shipments from its Wilmington Terminal. The Partnership will continue to assess any temporary impact on its operations and expects to provide an update as more information becomes available.
ORCL

Hot Stocks

16:15 EDT Oracle CEO Catz says 'we are off to an excellent start' - "We are off to an excellent start with Q1 non-GAAP earnings per share growing 19% in constant currency," said Oracle CEO, Safra Catz. "That strong earnings per share growth rate increases my confidence that we will deliver on another fiscal year of double-digit non-GAAP earnings per share growth." "The vast majority of ERP applications running in the cloud are either Oracle Fusion or Oracle NetSuite systems," said Oracle CEO, Mark Hurd. "In the first quarter, we increased our market share as customers continued to buy Oracle Fusion ERP to replace their existing SAP and Workday ERP systems. The Oracle Fusion ERP customer count is now nearly 5,500, while the NetSuite ERP customer count is over 15,000. Virtually every analyst ranks Oracle as the market leader in cloud ERP." "The Oracle Autonomous Database is now available on our second generation, highly-secure "Bare-Metal" cloud infrastructure," said Oracle CTO, Larry Ellison. "Oracle's Autonomous Database is faster, easier-to-use, more reliable, more secure and much lower cost than Amazon's databases. And Oracle is the only database that can automatically patch itself while running to protect your data from data theft. These are just some of the reasons why Amazon uses the Oracle database to run its business."
HMI

Hot Stocks

16:14 EDT Huami announces launch of new Amazfit Verge smart watch - Huami announced the launch of the Amazfit Verge - the Amazfit smart watch, that brings new, customizable features to the smart wearables industry. The Verge is the first watch of the new Amazfit smart watch product line in addition to the existing smart sports watch product line. The Verge offers many new and improved features to enrich the user experience including a 1.2G dual core processor, running Huami Watch OS based on the Android infrastructure with remarkable extensibility that allows downloads and operation of third-party Apps. The Verge also comes with a 1.3-inch full color AMOLED round screen as well as optimized power consumption that provides an industry-leading five days of battery life on a single charge. More importantly, the Verge is capable of making and receiving phone calls directly via blue-tooth connected mobile phones and displaying real time messages, including WeChat and incoming phone call alerts, all of which allow users to more conveniently stay connected with their friends, family and business associates.
ORCL

Hot Stocks

16:12 EDT Oracle reports Q1 adjusted operating margin 41%
SYMC

Hot Stocks

16:12 EDT Symantec, Starboard announced board refreshment plan - Symantec announced that its board of directors has enacted a refreshment plan, including the appointment of new independent directors to the company's board. Symantec and Starboard Value LP, an investment firm whose affiliated funds own approximately 5.8% percent of the company's common stock, collaborated on the director appointments. The appointments to Symantec's board include: Peter A. Feld, Managing Member of Starboard Value, who will join the board effective immediately; Dale L. Fuller, who will join the board effective immediately; and Richard S. "Rick" Hill, who will join the board following the 2018 Annual Meeting of Stockholders. In accordance with the existing director retirement policy under Symantec's Corporate Governance Guidelines, Robert S. "Steve" Miller is not standing for re-election at the 2018 Annual Meeting. In addition, Geraldine B. "Gerry" Laybourne has determined not to stand for re-election to the board. As part of its ongoing refreshment process, the board will also identify an additional independent Board member, mutually agreeable to Symantec and Starboard, to be added following the 2018 Annual Meeting. With the addition of these independent directors, and the planned retirement of Miller and Laybourne, the Symantec board will have 13 members. The agreement includes other customary provisions and in connection with today's announcement, Starboard will withdraw its slate of director nominees and vote all of its shares in favor of each of the company's board nominees at the 2018 Annual Meeting, and will abide by customary standstill provisions and voting commitments. Additional information about today's announcement will be filed on a Form 8-K with the U.S. Securities and Exchange Commission.
ORCL

Hot Stocks

16:11 EDT Oracle CEO Catz says 'we are off to an excellent start' - "We are off to an excellent start with Q1 non-GAAP earnings per share growing 19% in constant currency," said Oracle CEO, Safra Catz. "That strong earnings per share growth rate increases my confidence that we will deliver on another fiscal year of double-digit non-GAAP earnings per share growth." "The vast majority of ERP applications running in the cloud are either Oracle Fusion or Oracle NetSuite systems," said Oracle CEO, Mark Hurd. "In the first quarter, we increased our market share as customers continued to buy Oracle Fusion ERP to replace their existing SAP and Workday ERP systems. The Oracle Fusion ERP customer count is now nearly 5,500, while the NetSuite ERP customer count is over 15,000. Virtually every analyst ranks Oracle as the market leader in cloud ERP." "The Oracle Autonomous Database is now available on our second generation, highly-secure "Bare-Metal" cloud infrastructure," said Oracle CTO, Larry Ellison. "Oracle's Autonomous Database is faster, easier-to-use, more reliable, more secure and much lower cost than Amazon's databases. And Oracle is the only database that can automatically patch itself while running to protect your data from data theft. These are just some of the reasons why Amazon uses the Oracle database to run its business."
IBP

Hot Stocks

16:11 EDT Installed Building Products acquires Water-Tite Solution - Installed Building Products announced the acquisition of Water-Tite Solution. Founded in 2001, Water-Tite provides commercial waterproofing installation services in the Tampa, Florida market and has annual revenue of over $6.0M.
ORCL

Hot Stocks

16:09 EDT Oracle reports Q1 short-term deferred revenues were up 2% to $10.3B
UNVR NXEO

Hot Stocks

16:09 EDT Univar to acquire Nexeo Solutions for $11.65 per share in cash, stock - Univar (UNVR) and Nexeo Solutions (NXEO) announced they have entered into a definitive agreement for Univar to acquire Nexeo in a cash and stock transaction valued at approximately $2.0B, including the assumption of Nexeo's debt and other obligations, or $11.65 per Nexeo share. The merger agreement provides for each share of Nexeo stock issued and outstanding to be converted into 0.305 shares of Univar common stock and $3.29 in cash, subject to adjustment at closing, representing a purchase price of $11.65 per share of Nexeo common stock, based on Univar's closing price on September 14 of $27.40. The cash consideration is subject to a potential reduction of up to 41c per share, based on Univar's stock trading price prior to the completion of the acquisition. The transaction is expected to deliver $100M, or approximately 43c per share, after tax, in annual run-rate cost savings by the third year following close, and immediately reduce ongoing annual capital expenditures by $15M. It is expected to be accretive to Univar's adjusted EPS beginning in the first full year following closing. Univar expects pro forma leverage ratio to be below 3.0x by the end of the first full year after closing. The transaction has been unanimously approved by the boards of both companies, and is anticipated to close in the first half of 2019, subject to the approval of both Univar and Nexeo shareholders, as well as receipt of regulatory approvals and satisfaction of other customary conditions. Nexeo's key stockholders, TPG and First Pacific, have agreed to provide consent for the proposed transaction.
ORCL

Hot Stocks

16:08 EDT Oracle reports Q1 Cloud Services and License Support revenues $6.6B - Total Cloud Services and License Support plus Cloud License and On-Premise License revenues were up 2% to $7.5B. Cloud Services and License Support revenues were $6.6B, while Cloud License and On-Premise License revenues were $867M. Without the strengthening of the U.S. dollar compared to foreign currencies, Oracle's reported GAAP and non-GAAP Total Revenues would have been $66M higher, and Earnings Per Share would have been 1 cent higher.
UNVR NXEO

Hot Stocks

16:06 EDT Univar to acquire Nexeo Solutions for $11.65 per share in cash, stock
ORCL

Hot Stocks

16:06 EDT Oracle raises share repurchase authorization by $12B
MDRX

Hot Stocks

16:03 EDT Allscripts announces partnership between EPSi and Ilerasoft - EPSi, Allscripts budgeting, long-range planning, cost accounting and financial decision support platform, announced a partnership with Ilerasoft to offer clients additional capital budgeting capabilities and to provide analytics to help improve operational efficiency around medical equipment use powered by Ilerasoft's Efficiency Score. The Ilerasoft solution contextualizes medical equipment use with financial, operational and patient population metrics, and then provides recommendations to improve utilization and reduce costs, enabling decision makers in finance, supply chain and clinical engineering to use their own data to make long-term capital budgeting, resource allocation and purchasing decisions.
ALGT

Hot Stocks

16:02 EDT Par Investment reports 9.2% passive stake in Allegiant Travel
NXEO

Hot Stocks

16:00 EDT Nexeo Solutions trading halted, news pending
TYL

Hot Stocks

15:55 EDT Tyler Technologies CFO Brian Miller sells $1.4M worth of company stock - Tyler Technologies CFO Brian Miller disclosed in a filing that he had sold 5,652 shares of Tyler Technologies stock at an average price of $249.64 per share between September 13 and September 14. The total transaction value of the sale was $1,410,975
AMZN

Hot Stocks

15:55 EDT Amazon to open second large-scale facility in Stockton - Amazon announced plans to open its second large-scale facility in Stockton. The new fulfillment center will create more than 1,000 full-time jobs with competitive hourly wages and a comprehensive benefits package including healthcare, 401k and company stock awards starting on day one. Other Amazon fulfillment facilities in Central and Northern California are located in Fresno, Newark, Patterson, Sacramento, Tracy and Vacaville. Amazon has created more than 39,000 jobs in California and since 2011 invested over $19B in the state, including infrastructure and compensation to its employees. "Since we first began operating in California six years ago, we have found a network of support from community leaders, a dedicated workforce and fantastic customers," said Mark Stewart, Vice President of Amazon's North America Operations. "We're excited to expand in Stockton and develop our employees through on-the-job skills training and through our Career Choice program, which hundreds of our California associates have used to go back to school."
ADAP

Hot Stocks

15:51 EDT New Enterprise Associates 14 reports 15.2% stake in Adaptimmune
BHC

Hot Stocks

15:04 EDT Bausch Health CFO Paul Herendeen buys 10K shares of company stock - Bausch Health CFO Paul Herendeen disclosed in a filing that he had purchased 10,000 shares of company stock at an average price of $22.61 per share on September 14. The total transaction value of the purchase was $226,100.
BA

Hot Stocks

15:04 EDT Boeing says senior VP of Communications to depart in early November - Boeing announced that Phil Musser, senior vice president of Communications, will depart the company in early November due to personal and family considerations. Anne Toulouse, current Boeing vice president of Global Brand Management, will replace Musser on an interim basis until a permanent successor is named.
AET...

Hot Stocks

15:03 EDT Aetna up 1% after DOJ clears Cigna deal with Express Scripts - Cigna (CI) announced that the Antitrust Division of the United States Department of Justice has cleared its pending merger with Express Scripts (ESRX). Shares of Aetna (AET), which has agreed to merge with CVS Health (CVS), are up 1% following Cigna's announcement.
CI ESRX

Hot Stocks

14:52 EDT Department of Justice grants clearance to Cigna acquisition of Express Scripts - Cigna Corporation (CI) and Express Scripts (ESRX) announced that the Antitrust Division of the United States Department of Justice has cleared their pending merger, terminating the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. "We are pleased that the Department of Justice has cleared our transaction and that we are another step closer to completing our merger and delivering greater affordability, choice and predictability to our customers and clients as a combined company," said David Cordani, President and CEO of Cigna. Completion of the transaction remains subject to certain state regulatory approvals and filings required in connection with the transaction, including clearances from certain departments of insurance, and the satisfaction of all closing conditions. To date, Cigna and Express Scripts have obtained clearances from departments of insurance in 16 states. The companies are working constructively with regulators in the remaining jurisdictions to obtain clearance for the merger. Cigna and Express Scripts continue to anticipate that the deal will close by year-end 2018, subject to the satisfaction of all closing conditions.
CI ESRX

Hot Stocks

14:50 EDT Department of Justice grants clearance to Cigna acquisition of Express Scripts
NTNX...

Hot Stocks

14:31 EDT Nutanix slips as Google Cloud reportedly tests devices for private data centers - Shares of cloud computing software company Nutanix (NTNX) are slipping in afternoon trading after The Information reported that Google Cloud (GOOG) is testing devices for private data centers. WHAT'S NEW: Google Cloud is building custom-designed computers for "a handful" of large customers to run in private data centers, The Information reported, citing two people with knowledge of the project. The devices are the latest indication of Google's increasing focus on cloud products that run under the direct control of corporate customers, the report added. The Information noted that it is not certain whether Google will take the extra step and sell such devices to a broader range of customers, though doing so would signal a shift in the company's cloud strategy for attracting Fortune 500 customers. PRICE ACTION: In afternoon trading, Nutanix shares are down 7.6% to $48.51. Nutanix offers cloud software and hyperconverged infrastructure solutions. Reference Link
SMIT

Hot Stocks

14:21 EDT Sententia, in letter to Schmitt holders, calls shares significantly undervalued - Sententia Capital Management, the beneficial owners of approximately 8.1% of the outstanding shares of common stock of Schmitt Industries, Inc. and one of the company's largest shareholders, announced that it has delivered a letter to fellow Schmitt shareholders. "Sententia believes Schmitt is comprised of good businesses, strong brands, an attractive long-term profile, and the ability to generate strong free cash flow. However, these features are hidden under leadership and a Board that Sententia believes continues to lack accountability, transparency and alignment, evident in their recent communications and proxy. Sententia has a concrete plan to maximize shareholder value and has formally nominated two highly qualified candidates for election to the Board at Schmitt's 2018 annual meeting," the firm stated in its announcement of the letter.
NVS...

Hot Stocks

14:14 EDT Americans deserve to know lowest drug price at their pharmacy, Trump says - President Donald Trump tweeted: "Americans deserve to know the lowest drug price at their pharmacy, but "gag clauses" prevent your pharmacist from telling you! I support legislation that will remove gag clauses and urge the Senate to act. #AmericanPatientsFirst" Publicly traded large-cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded retail pharmacy operators include CVS Health (CVS), Walgreens Boots Alliance (WBA) and Rite Aid (RAD). Reference Link
C

Hot Stocks

14:05 EDT Citi reports August credit loss 2.56% vs. 2.66% last month - Reports August 30-plus day delinquency rate 1.49% vs. 1.47% last month.
AAPL

Hot Stocks

13:27 EDT Apple says iOS 12 available as a free software update - In a statement from earlier, Apple said :"IOS 12, the latest version of the most advanced mobile operating system, is designed to make everyday tasks on iPhone and iPad faster and more responsive. Available today as a free software update, iOS 12 introduces new AR experiences, fun new features like Memoij, Siri Shortcuts that open up a world of apps to work with Siri and new tools to help people reduce interruptions and manage screen time for themselves and their families." Reference Link
DUK

Hot Stocks

13:26 EDT Duke Energy says power restored to roughly 1.2M in Carolinas, 300K left to fix - Duke Energy said its crews are fully focused on restoring power to the remaining 300,000 customers who lost electricity when Hurricane Florence rolled through the Carolinas. As of 1 p.m. ET Monday, the company has experienced a total of 1.5M outages throughout the storm event. Duke Energy has restored power to roughly 1.2M. Many of the remaining impacted customers are located in tough-to-access coastal areas that experienced historic flooding, multiple road closures and significant structural damage, according to the company.
SHOP AAPL

Hot Stocks

13:15 EDT Shopify utilizes Apple's AR Quick look in its platform - "Augmented reality has the potential to revolutionize mobile shopping by bringing products to life in front of you through 3D models that you can size up, examine from all angles, and even place in the environment around you...With Apple's (AAPL) recent announcement of AR Quick Look, we can now enable these 3D models to be viewable in AR directly through the Safari browser on iOS 12 devices-without the need for a separate mobile app or a clunky headset, said Shopify (SHOP) in an earlier blog posting. "Web-powered augmented reality represents an exciting leap toward making AR experiences readily available to the everyday shopper through mobile browsers," added the Canadian commerce company. Reference Link
MYND

Hot Stocks

13:06 EDT MYnd Analytics expands relationship with Claremont Behavioral Services - MYnd Analytics announced that its wholly owned subsidiary, Arcadian Telepsychiatry Services LLC, has expanded its relationship with Claremont Behavioral Services Inc, a provider of Employee Assistance Programs. Under the new agreement, Arcadian will provide Claremont's members and employees outside of California with nationwide services through its provider network following a successful pilot program.
AAPL

Hot Stocks

13:05 EDT Kudlow says Apple CEO Tim Cook 'loved' Trump's tax reform - Director of the National Economic Council Larry Kudlow, while speaking at the Economic Club in New York, said Apple CEO Tim Cook told both him and President Trump that he "loved" the administration's tax reform.
TJX

Hot Stocks

13:01 EDT TJX board approves 2-for-1 stock split - TJX Companies announced that its board of directors has approved a 2-for-1 stock split of the company's common stock by means of a stock dividend. Implementation of the stock split is subject to approval by TJX shareholders of an increase in the number of authorized shares of the company's common stock from 1.2B shares to 1.8B shares, and related board approval. The increase will be voted on at a special shareholders meeting that is anticipated to be held on October 22, 2018, at which shareholders of record on September 27, 2018 would be entitled to vote. If approved, one additional share of the company's common stock would be distributed on November 6, 2018 for each share held by shareholders of record on October 30, 2018. The company also announced the declaration of a quarterly dividend on its common stock of 39c per share, on a pre-stock split basis, payable December 6, 2018, to shareholders of record on November 15, 2018. If the stock split is effected before the quarterly dividend payment, the quarterly dividend will be adjusted accordingly to 19.5c per share.
MTRX

Hot Stocks

12:59 EDT Matrix Service CFO sells 21,450 common shares - In a regulatory filing, Matrix Service VP of finance and CFO Kevin S. Cavanah disclosed the sale of 21,450 common shares of the company at a price of $25.4042 per share.
UNT

Hot Stocks

12:47 EDT Unit Corp. officer Robert Parks sells almost 23K shares of company stock - Unit Corp. officer Robert Parks disclosed in a filing that he had sold 22,806 shares of company stock at an average price of $27.25 per share between September 13 and September 14. The total transaction value of the sale was $621,438.
HMNY AMC

Hot Stocks

12:27 EDT Helios and Matheson plunges amid plans to seek approval for reverse stock split - Shares of MoviePass parent Helios and Matheson Analytics (HMNY) continued their plunge on Monday after a filing with the Securities and Exchange Commission showed that the company will seek approval for an up to 1-for-500 reverse stock split. The filing follows Helios and Matheson's 1-for-250 reverse stock split in July and comes amid the financial bleeding of its earlier business model. NEW REVERSE STOCK SPLIT: In a regulatory filing on Monday, Helios and Matheson said it will hold a special meeting with stockholders in October to approve an amendment for a one-time reverse stock split of up to 1-for-500 shares. The parent of movie-ticket subscription service MoviePass announced a 1-for-250 share reverse stock split on July 24, which began began trading on a split-adjusted basis on July 25. In this filing, Helios and Matheson said this new stock split could range from 1-for-2 to 1-for-500. WHAT'S NOTABLE: The proposed reversed stock split is the latest attempt by Helios and Matheson to reinvigorate the stock, which is at risk of being delisted from the Nasdaq if it continues to trade below $1 with a market cap under $50M. In July, the company disclosed in a regulatory filing it had to borrow $5M in cash after the MoviePass app temporarily shut down. MoviePass CEO Mitch Lowe announced in an all-hands meeting in late July that it would limit ticket availability to upcoming blockbuster movies during the first two weeks and implied that the practice of not offering tickets to major movies would continue for the foreseeable future. The company said other actions that have been implemented are currently cutting the monthly burn by 60% included a future increase of the standard pricing plan to $14.95 per month. Ted Farnsworth, chairman and CEO of Helios, said the changes "are meant to protect the longevity of our company and prevent abuse of the service. While no one likes change, these are essential steps to continue providing the most attractive subscription service in the industry." In late August, MoviePass director Carl Schramm resigned from the company's board, alleging that management kept him in the dark about crucial information and made it impossible for him to do his job. Schramm cited "concerns about the corporate governance" at the company and said a "number of business decisions" were presented to the board without enough time for them to review documents. WOES PRESENT OPPORTUNITY FOR COMPETITORS: As MoviePass has struggled to quell the financial bleeding of its business model, theater companies and other competitors have sprung up to grab a share of users that have been disgruntled by the company's recent changes, The Wall Street Journal reported on Monday. According to the report, competing service Sinemia announced a sale that offers three movies a month at $9.99 and cinema chain AMC Entertainment Holdings (AMC) introduced a $19.95 monthly offering of three movies a week at its theaters, which has attracted over 260,000 subscribers as of August. PRICE ACTION: Shares of Helios and Matheson have lost most of their value and now trade at just 1.7c per share.
CDE

Hot Stocks

12:10 EDT Coeur Mining reports fatal accident at Palmarejo on September 13 - Coeur Mining regrets to report that a fatal accident occurred at its Palmarejo Mine in Mexico on September 13, 2018. Two underground production drillers fell into a void after the ground below them collapsed. The area was immediately evacuated and all underground operations were suspended pending emergency response and initial investigation. The Company is working closely and cooperatively with the authorities to respond to the situation. The ground collapse occurred in a highly localized area and does not affect other portions of the mine. Operations have resumed except in the specific level of the underground mine where the incident occurred. A formal investigation has begun to determine the root causes of the incident as well as how to prevent them in the future.
ST

Hot Stocks

12:00 EDT Sensata falls -5.5% - Sensata is down -5.5%, or -$2.91 to $49.81.
NWY

Hot Stocks

12:00 EDT New York & Co. falls -5.8% - New York & Co. is down -5.8%, or -24c to $3.88.
LPL

Hot Stocks

12:00 EDT LG Display falls -5.8% - LG Display is down -5.8%, or -54c to $8.72.
CEL

Hot Stocks

12:00 EDT Cellcom Israel rises 10.1% - Cellcom Israel is up 10.1%, or 61c to $6.67.
FF

Hot Stocks

12:00 EDT FutureFuel rises 11.1% - FutureFuel is up 11.1%, or $1.76 to $17.62.
GHG

Hot Stocks

12:00 EDT GreenTree Hospitality rises 14.7% - GreenTree Hospitality is up 14.7%, or $1.63 to $12.72.
APD

Hot Stocks

11:50 EDT Air Products raises North America prices for liquid and bulk gas products - Effective October 1, or as contracts permit, Air Products will increase product pricing, monthly service charges, and surcharges for merchant customers in North America. The pricing adjustments include increases of;Up to 25% for liquid and bulk hydrogen. Up to 20% for liquid argon. Up to 15% for liquid nitrogen and liquid oxygen. Up to 10% for liquid carbon dioxide and monthly service charges. Some price adjustments may be outside of these ranges based on specific situations. Helium prices will also be increased based on supply/demand and cost situations and may be customer specific. These adjustments are in response to increases in sourcing, production and delivery costs, and support continued investments in reliability, security, and safety.
WHR F

Hot Stocks

11:05 EDT Whirlpool announces J Mays as new Chief Design Officer - J Mays is joining Whirlpool (WHR) as Vice President and Chief Design Officer. His role is effective October 15, 2018. Prior to joining Whirlpool, Mays was Group Vice President of Global Design and Chief Creative Officer at Ford (F).
HMNY

Hot Stocks

11:01 EDT Helios and Matheson to seek approval for up to 1-for-500 reverse stock split - In a regulatory filing, MoviePass parent Helios and Matheson said it will look to approve up to a 1-for-500 reverse stock split during a special meeting with stockholders in October. The Fly notes that Helios and Matheson announced a 1-for-250 share reverse stock split on July 24. The reverse stock split was approved by shareholders on July 23 and the common stock began trading on a split-adjusted basis on Wednesday, July 25.
VVV AMZN

Hot Stocks

10:58 EDT Street Fight: Analysts diverge on Valvoline over Amazon concerns - On Monday, Seaport Global analyst Michael Harrison upgraded Valvoline (VVV) to Buy, saying last week's selloff was "overblown." The upgrade came after JPMorgan analyst Jeffrey Zekauskas on Friday downgraded Valvoline to Underweight on a report that Amazon (AMZN) had launched a private label motor oil called AmazonBasics Full Synthetic Motor Oil. SELOFF 'OVERBLOWN': On Monday, Seaport Global analyst Michael Harrison upgraded Valvoline to Buy from Neutral and maintained a $25 price target. Harrison said he believes last week's selloff was "overblown" and an excellent buying opportunity to get involved in the growth story driven by Quick Lubes and International. The analyst said reaction to concerns about Amazon's private-label competition were overdone as cheaper alternatives already exist, do-it-yourself customers like branded products and shopping in brick-and-mortar locations and Amazon's entry will likely have no impact on the do-it-for-me business. In addition, Harrison said he expects normalizing trends in the core North American segment in the fourth quarter, noting base oil prices appear to be stabilizing, which should help the company catch up on the price/cost front. He added that he continues to see announcements that Valvoline is adding stores to its quick-lube network and believes there is plenty of runway for additional store count growth. JPMORGAN LESS OPTIMISTIC: On Friday, JPMorgan analyst Jeffrey Zekauskas downgraded Valvoline to Underweight from Neutral and lowered his price target for the shares to $20 from $22. In a research note of his own, Zekauskas noted that Industry trade publication National Oil and Lube News reported that Amazon has launched its first private label motor oil supplied by Warren Distribution. The analyst pointed out that the product line is now being reviewed favorably by Amazon Vine Reviewers. He added while it's too early to gauge the effects of the Amazon entry on the Valvoline brand, the new competition from Amazon will likely reduce Valvoline's trading multiple "because the lubricant industry structure is probably weaker for its entry." PRICE ACTION: Valvoline rose 1.5% to $21.04 in late morning trading.
ORMP

Hot Stocks

10:37 EDT Oramed receives FDA clearance for IND application for ORMD-0901 - Oramed Pharmaceuticals announced that the FDA has cleared its Investigational New Drug, or IND, application for human trials of its oral GLP-1 analog capsule ORMD-0901. Oramed's planned Phase 1 pharmacokinetic study is a fully-randomized, single-blind, placebo-controlled 4-way crossover study which will evaluate safety in addition to the pharmacokinetics of ORMD-0901 compared to placebo and to open label Byetta, a GLP-1 analog currently on the market, in up to 15 healthy subjects.
TNDM

Hot Stocks

10:33 EDT Tandem Diabetes dip attributed to secondary lock-up expiration - Shares of Tandem Diabetes Care are trading lower, which is being attributed to the expiration of a lock-up related to a secondary offering of stock the company announced in August. On August 2, Tandem Diabetes announced a 3.51M share secondary offering of stock that priced at $28.50 per share and raised $100M. Today is the first day some shareholders and company insiders get to sell their shares in the healthcare safety device maker related to that secondary offering, according to Bloomberg data. In morning trading, Tandem dropped $6.54, or 13.7%, to $41.09 per share.
ARGX

Hot Stocks

10:29 EDT Argenx reports Phase 2 proof-of-concept clinical trial of efgartigimod - Argenx earlier this morning announced "positive" topline results from its Phase 2 proof-of-concept clinical trial of efgartigimod in adult primary immune thrombocytopenia patients. The Phase 2 data of efgartigimod showed a favorable safety and tolerability profile consistent with the Phase 1 healthy volunteer trial and the Phase 2 proof-of-concept trial in generalized myasthenia gravis, the company said. Patients treated with efgartigimod exhibited clinically meaningful platelet count improvements across doses and ITP patient classifications, including newly diagnosed, persistent and chronic, and correlated with a consistent reduction in IgG levels, it added. The primary endpoint of the Phase 2 trial was safety and tolerability. Efgartigimod was reported to be well-tolerated in all patients, with most adverse events characterized as mild and deemed unrelated to the study drug. One serious adverse event was reported in the primary study and was deemed unrelated to the study drug. 46% of the 38 patients enrolled improved platelet count to greater than 50x109/L during two or more visits in each of the 5mg/kg and 10 mg/kg dosing cohorts compared to 25% in the placebo cohort. 58% of patients improved platelet count to greater than 50x109/L during two or more visits following the first dosing cycle of the open-label extension study. Based on these data, Argenx plans to advance efgartigimod to Phase 3 development in ITP. The company also expects to initiate a Phase 2 trial in ITP using a subcutaneous formulation of efgartigimod. Efgartigimod is currently being evaluated in a global Phase 3 registration trial in gMG and a Phase 2 proof-of-concept trial in pemphigus vulgaris. "These data highlight the differentiating features of efgartigimod in this difficult-to-treat disease. Efgartigimod has the potential to address ITP in a novel way across patient types, targeting disease at the source by eliminating IgGs and restoring platelet numbers. Also, efgartigimod continues to be well-tolerated, which we attribute to the unique binding characteristics of our Fc fragment and view as an important advantage in this new therapeutic class. We intend to leverage our leadership position in the FcRn antagonist space and advance efgartigimod in ITP to reach patients as quickly as possible," commented Nicolas Leupin, Chief Medical Officer of Argenx.
FOXA...

Hot Stocks

10:25 EDT Box Office Battle: "The Predator" wins weekend despite historically bad opening - As predicted, this past weekend's major new film release, 21st Century Fox's (FOX, FOXA) "The Predator," the fourth installment in the "Predator" action movie series, took the top spot at the box office with a domestic gross of $24M. However, the film, which opened at 4,037 theaters, had the worst opening ever for a live-action film that opened at over 4,000 locations. Internationally, "The Predator" added another $30.7M in 72 markets. AT&T (T) subsidiary Warner Bros' "The Nun" finished in second place for the weekend, declining 66% to earn an additional $18.2M domestically in its second weekend at theaters. Internationally, "The Nun" added $33.1M. Rounding out the top five for the weekend were Lionsgate's (LGF.A, LGF.B) opening of thriller "A Simple Favor," which earned $16M, Studio 8's crime drama "White Boy Rick," which earned $8.8M, and Warner Bros. "Crazy Rich Asians, which added another $8.7M in its fifth weekend of release. Other publicly traded companies in filmmaking include Comcast (CMCSA, CMCSK), Disney (DIS), Sony (SNE), and Viacom (VIA, VIAB).
GD

Hot Stocks

10:17 EDT General Dynamics awarded $481M contract modification from U.S. Navy - The U.S. Navy has awarded General Dynamics Electric Boat a $480.6M contract modification to continue the development of the lead Columbia-class submarine, the nation's next-generation sea-based strategic deterrent. Electric Boat is a wholly owned subsidiary of General Dynamics. The modification includes funding for advance procurement, advance construction and long lead time material for Columbia. Construction of the lead ship of the class is scheduled to begin in the fall of 2020. The Navy plans to build a fleet of 12 new SSBNs. Initially awarded in September 2017, the overall contract has a potential value of $6.1B.
UPS

Hot Stocks

10:16 EDT UPS to hire about 100,000 for holiday season - UPS announced that it expects to hire about 100,000 seasonal employees to support the anticipated increase in package volume that will begin in November and continue through January 2019. The full- and part-time seasonal positions - primarily package handlers, drivers and driver-helpers - have long been an entry point for permanent employment at UPS. Many senior UPS executives, including CEO David Abney and other members of the company's senior leadership team, started their UPS careers as part-time employees. Over the last three years, 35% of the people UPS hired for seasonal package handler jobs were later hired in a permanent position when the holidays were over.
EPAM

Hot Stocks

10:05 EDT EPAM, Positive partner on research-driven Cybersecurity R&D Lab - EPAM Systems announced that it will partner with Positive on a research-driven Cybersecurity R&D Lab. The Lab will address the evolving need for advanced consulting capabilities in the fast-growing area of cybersecurity, and conduct much-needed research in the areas of security solutions and services, as well as establish a network of both internal and external experts. To help its customers safeguard their data, the Cybersecurity R&D Lab, operating as part of EPAM's network of Garages, will contribute to global cybersecurity community research and complement EPAM's capabilities across a range of information security domains.
BWA

Hot Stocks

10:04 EDT BorgWarner to supply P2 on-axis hybrid modules to Chinese automakers - BorgWarner has been selected to supply its state-of-the-art on-axis P2 drive module and electro-hydraulic control unit for hybrid-electric vehicles to two leading Chinese original equipment manufacturers. This new business award is the result of close collaboration between the company's global research and development centers and strong local Chinese engineering capability. With these two recent awards, BorgWarner will now have content on 18 P2 hybrid transmissions by 2023 serving various global OEMs and spanning multiple vehicle platforms.
GPS

Hot Stocks

10:03 EDT Gap to hire 65,000 seasonal associates for the holidays - Gap announced plans to hire approximately 65,000 seasonal associates for its Gap, Banana Republic, Athleta and Old Navy stores, as well as call centers and distribution centers for the 2018 holiday season. The company invites applicants to come onsite at all Gap, Gap Outlet, Banana Republic, Banana Republic Factory, Old Navy stores and select distribution and call centers for Gap Inc.'s holiday hiring event in the United States on October 6, 2018 and in Canada on October 13, 2018 from 10 a.m. to 2 p.m. in local time zones. Store job candidates are encouraged to apply for a position prior to the holiday hiring events through Gap Inc.'s seasonal hiring career page and distribution and call center candidates through Gap Inc.'s career page. Athleta and Phoenix distribution center will not host onsite interviews but will be recruiting for the holiday season through the career page. Seasonal positions vary by location but include serving customers on the sales floor at Gap, Banana Republic, Athleta and Old Navy stores by helping find the right size and style through our In Stock On Shelf app, which informs proactively the store associates on their mobile devices when items need replenishing. Non-store positions can involve coordinating shipments from our distribution centers to stores, fulfilling customers' orders from online, via mobile or in store, and handling the high volume of calls at customer call centers. Seasonal associates will enjoy the same merchandise discount, wellness offerings and flexible scheduling as the company's current associates. Gap Inc.'s employee merchandise discount includes 50% off regular-priced merchandise at Gap, Banana Republic and Old Navy stores; 30% off at Outlet and Factory stores; and 25% off at Athleta stores.
CAR

Hot Stocks

10:01 EDT Avis Budget extends partnership with Maple Leaf Sports & Entertainment - Avis announced that it has renewed its multi-year agreement with Maple Leaf Sports & Entertainment to continue its designation as the official vehicle rental partner of the Toronto Maple Leafs and Toronto FC. Under the agreement, the mobility brand will have the opportunity to promote its products and services to millions of sports fans and visitors of Scotiabank Arena and BMO Field. Program elements include arena signage, camera-visible signage during games, events, in-market advertising and promotional opportunities.
BRFS

Hot Stocks

10:00 EDT BRF S.A. rises 6.7% - BRF S.A. is up 6.7%, or 34c to $5.30.
PYX

Hot Stocks

10:00 EDT Pyxus rises 7.8% - Pyxus is up 7.8%, or $1.45 to $20.05.
CEL

Hot Stocks

10:00 EDT Cellcom Israel rises 10.5% - Cellcom Israel is up 10.5%, or 64c to $6.70.
KO...

Hot Stocks

09:56 EDT Cannabis stocks rise amid interest by Coca-Cola, opportunities for Shopify - Shares of cannabis stocks are in focus following a report that Coca-Cola (KO) is in talks with Aurora Cannabis (ACBFF) as it eyes the cannabis industry and an analyst note from Keybanc which said Shopify (SHOP) has cannabis potential. COCA-COLA EYES CANNABIS: Coca-Cola is monitoring the nascent cannabis drinks industry and is in talks with Canadian marijuana producer Aurora Cannabis to develop the drinks, Bloomberg reported Monday. "We are closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around the world," Coca-Cola spokesman Kent Landers said. "The space is evolving quickly. No decisions have been made at this time" Landers added. The move comes as beverage makers are looking towards cannabis as soda consumption and traditional business slows. Constellation Brands (STZ, STZ.B) previously announced it will spend $3.8B to increase its stake in Canadian marijuana producer Canopy Growth (CGC) and Molson Coors Brewing (TAP) is starting a joint venture with Quebec's Hydropothecary to develop cannabis drinks. In addition, Diageo (DEO) has been holding talks with at least three Canadian cannabis producers regarding a potential deal and Heineken's (HEINY) Lagunitas label has launched a brand focused on non-alcoholic drinks infused with THC. SHOPIFY MAY BENEFIT FROM CANNABIS SALES: KeyBanc analyst Monika Garb told investors in a research note on Monday that she is a buyer of Shopify, as the company has "ample" growth opportunities ahead. She sees potential upside to her above-consensus estimates and expects that recreational sales of cannabis in Canada could be a general merchandise volume and revenue driver further benefiting Shopify's business momentum. The analyst said the company has been selected by several Canadian provinces to run their e-commerce sites and in-store point of sale solutions and has also signed deals with private cannabis producers and distributors, including Canopy Growth and Aurora. Additionally, Garb says Shopify is the best positioned to benefit from growth in emerging brands, citing brands like Rebecca Minkoff and Kyle Cosmetics that already use Shopify. Garb maintained an Overweight rating and $182 price target on shares. CANNABIS STOCKS: Publicly-traded companies in the space include Cronos Group (CRON), Canopy Growth, Tilray (TLRY), Cannabis Science (CBIS), Innovative Industrial Properties (IIPR) and Aurora Cannabis. PRICE ACTION: Aurora Cannabis gained over 16% in morning trading, while Tilray gained 7.3%.
ARCB

Hot Stocks

09:50 EDT ArcBest mentioned cautiously at Off Wall Street
LPL

Hot Stocks

09:47 EDT LG Display falls -4.8% - LG Display is down -4.8%, or -44c to $8.82.
ST

Hot Stocks

09:47 EDT Sensata falls -5.7% - Sensata is down -5.7%, or -$3.03 to $49.69.
FET

Hot Stocks

09:47 EDT Forum Energy falls -7.5% - Forum Energy is down -7.5%, or -85c to $10.55.
WAB

Hot Stocks

09:47 EDT Wabtec rises 7.1% - Wabtec is up 7.1%, or $6.97 to $105.18.
TEVA

Hot Stocks

09:47 EDT Teva rises 6.3% - Teva is up 6.3%, or $1.43 to $24.28.
CEL

Hot Stocks

09:47 EDT Cellcom Israel rises 8.3% - Cellcom Israel is up 8.3%, or 50c to $6.56.
TSLA

Hot Stocks

09:46 EDT Tesla in 'delivery logistics hell' amid plans to in-source collision repairs - Shares of Tesla (TSLA) are in focus in early trading following reports that a fire broke out at the company's Nevada Gigafactory this weekend. Additionally, CEO Elon Musk tweeted this weekend that the company is now in "delivery logistics hell" and claimed that Tesla will now perform most collision repairs in-house. FIRE: A fire broke out at Tesla's Gigafactory in Nevada late on Saturday but was contained by early Sunday and production had resumed, Reuters reported, citing emergency officials and the company. The factory produces Model 3 electric motors and battery packs. No injuries were reported. Saturday's fire was the latest fire at a Tesla factory after a factory in California suffered a minor fire last month. 'DELIVERY LOGISTICS HELL': Separately, CEO Elon Musk tweeted on Sunday in response to a customer complaint on delivery delays: "Sorry, we've gone from production hell to delivery logistics hell, but this problem is far more tractable. We're making rapid progress. Should be solved shortly." In August, Tesla said it expects to produce 50,000-55,000 Model 3 sedans in the third quarter and that it expects to turn a profit in the second half of this year. Tesla has been looking to smooth production snags after struggling to produce Model 3s and failing to meet several production deadlines. Last week, Musk tweeted that customers may face a longer response time because of a significant increase in vehicle delivery volume in North America. Musk also said last week that Tesla is taking two out of seven colors "off the menu" to simplify manufacturing. Obsidian Black and Metallic Silver will still be available as special requests, Musk tweeted, but at higher price point. BRINGING COLLISION REPAIRS IN-HOUSE: As Tesla struggles with the logistics of delivering its cars, Musk also tweeted this weekend that Tesla will bring most collision repairs in-house, "as outside firms take weeks to months for repairs, driving Tesla owners (and us) crazy." He added, "Exciting to see some Tesla collision repair operations already completing within 24 hrs. Aiming for same day soon, then under an hour...Goal is for repaired car to be better than before accident. Should always be true if damaged/used parts are correctly replaced with newer parts." WHAT'S NOTABLE: Musk has been under fire from investors recently for his tweets, including one that said he was considering taking Tesla private and had secured funding for the effort. On August 25, Musk said in a blog post that the company will remain public. Tesla now faces shareholder lawsuits as well as an investigation by the SEC. Additionally, Musk appeared on"The Joe Rogan Experience," a podcast hosted by stand up comic Joe Rogan, during which Rogan shared what he said was a cigarette with marijuana and tobacco with the CEO. Musk also drank whiskey and fired a flamethrower during the interview. The appearance on Rogan's show comes not long after a recent interview with The New York Times, in which Musk said he has no plans to relinquish the chairman and CEO roles, though efforts are under way to find a No. 2 executive to help take some of the pressure off. Also last week, Citron Research's Andrew Left filed a securities class action lawsuit against Tesla and Musk, alleging that the CEO "artificially manipulated the price of Tesla securities with objectively false tweets in order to 'burn' the company's short-sellers." Tesla's largest institutional investor said that the firm has spoken to U.S. securities regulators about Musk's plans to take the company private and that the CEO needs help running the car maker, Reuters reported last week. Last week, Tesla's stock was downgraded at Nomura Instinet to Neutral, with analyst Romit Shah telling investors that he believes Tesla is "no longer investable" due to Musk's recent behavior. PRICE ACTION: Shares of Tesla are lower by about 1% to $292.12 in early trading.
APD

Hot Stocks

09:34 EDT Air Products announces oxygen equipment pact with KCC Corporation - Air Products announced it has been awarded oxygen and oxy-fuel combustion equipment supply by KCC Corporation, the largest glass and construction material manufacturer in South Korea, for the new glass fiber production line at its Sejong site. The new production line is scheduled to come on-stream in 2019.
CYTX

Hot Stocks

09:32 EDT Cytori Therapeutics receives FDA orphan drug designation for ATI-1123 - Cytori Therapeutics announced that it received FDA orphan drug designation for its ATI-1123 chemotherapy drug product candidate, an albumin-stabilized pegylated liposomal docetaxel, for the treatment of small cell lung cancer. Small cell lung cancer, or SCLC, which accounts for approximately 15% of bronchogenic carcinomas with 33,375 new cases and 23,380 deaths estimated for 2017, has been identified by Cytori as a compelling target for ATI-1123. While SCLC is responsive to chemotherapy and radiation therapy, cure occurs only in 20% of patients, generally restricted to those with limited stage disease. The remaining 80% of patients, including all patients with extensive disease, relapse within months of completing their initial therapy. Availability of 2nd line therapy options are limited, toxic, and provide little benefit in terms of extending survival. Topotecan is the only FDA-approved agent for 2nd line treatment of SCLC and is associated with an overall response rate of 24%, median response duration or time to progression of 14 weeks, and median overall survival of 25 weeks. Treatment usually involves a consecutive 5 day regimen of either IV or oral administration of drug, both which have black box warnings for severe myelosuppression as their use is associated with substantial morbidity including bone marrow suppression leading to neutropenia, thrombocytopenia and anemia requiring interventions of transfusion and growth factor support. Cytori's ATI-1123 has been designed to fill this need. ATI-1123's combination of improved liposome stability, reduced toxicity, and superior delivery are expected to provide a therapeutic for SCLC that offers comparable or better efficacy to currently-available standards while having a less intensive administration routine and improved side effect profile. Cytori is also exploring the development of ATI-1123 to address the shortcomings of docetaxel, a workhorse chemotherapy drug which generated $2.7B in worldwide sales at its peak. Compared to docetaxel, ATI-1123 may have potential to improve safety by removing the need for unwanted solvents, reduce morbidity by eliminating the requirement for standard pretreatment medications, provide better patient convenience and comfort via less time spent in the treatment center, decrease the cost of therapy, and enhance systemic docetaxel exposure.
TRHC

Hot Stocks

09:28 EDT Tabula Rasa HealthCare subsidiary expands services with VNSNY - Tabula Rasa HealthCare announced its subsidiary, Mediture, is expanding services in a new market for TRHC with the Visiting Nurse Services of New York, or VNSNY, managed long-term care, or MLTC, plan in New York City. VNSNY serves the five boroughs of New York City and Nassau, Suffolk and Westchester Counties. VNSNY's MLTC program is a Medicaid plan designed for New Yorkers who want to remain in their own homes and communities, but need help with daily activities. The VNSNY MLTC plan is one of the largest in the state of New York. Currently, the Mediture platform is in the customization phase with the Visiting Nurse Service of New York (VNSNY). The services are scheduled to start December 1.
EMKR RTN

Hot Stocks

09:25 EDT Emcore awarded $18M contract to supply FOG modules to Raytheon - Emcore (EMKR) announced that it has been awarded a long-term contract valued at over $18M over a 4-year period to supply high-performance fiber optic gyroscope, or FOG, modules to Raytheon (RTN) for use in airborne optical targeting systems. Emcore has previously delivered over 1,000 units of its custom designed, closed-loop, single-axis FOGs to Raytheon and will ship additional units this year and over the remaining term of the agreement. The FOG modules to be delivered are Emcore's tethered gyros with separate electronics and sensor modules to accommodate the widest variety of installation parameters. The performance specifications of these FOGs are ideal for platform stabilization in camera systems used for optical targeting in aircraft, unmanned aerial vehicles and gun systems.
TSLA

Hot Stocks

09:23 EDT Aspiring Tesla rival announces $1B+ investment agreement with Saudi Arabia's PIF - Aspiring Tesla rival Lucid Motors announced that it has executed a $1B+ investment agreement with the Public Investment Fund of Saudi Arabia, through a special-purpose vehicle wholly owned by PIF. Under the terms of the agreement, the parties made binding undertakings to carry out the transaction subject to regulatory approvals and customary closing conditions. he transaction represents a major milestone for Lucid and will provide the Company with the necessary funding to commercially launch its first electric vehicle, the Lucid Air in 2020. Lucid plans to use the funding to complete engineering development and testing of the Lucid Air, construct its factory in Casa Grande, Arizona, begin the global rollout of its retail strategy starting in North America, and enter production for the Lucid Air.
SIR...

Hot Stocks

09:18 EDT Fly Intel: Pre-market Movers - HIGHER: Select Income REIT (SIR), up 16% after agreeing to merge with Government Properties Income Trust (GOV)... Teva (TEVA), up 6% after FDA approval of Ajovy injection for the treatment of migraine... Neptune Technologies (NEPT), up 20% after announcing that it has received a Confirmation of Readiness letter from Health Canada in regard to its application to become a Licensed Producer under the ACMPR... Senomyx (SNMX), up 41% after announcing that it has entered into a definitive merger agreement under which Firmenich will acquire all of the outstanding common stock of Senomyx for $1.50 per share in cash... NXP Semiconductors (NXPI), up 1% after BofA Merrill Lynch analyst Vivek Arya upgraded the stock to Buy based on a potential sales growth recovery driven by new auto/IoT products, a stronger balance sheet, free-cash-flow growth and buybacks. LOWER: Government Properties, down 16% after agreeing to merge with Select Income REIT... JD.com (JD), down 3% after a report that Richard Liu, the CEO of JD, will no longer attend a high-profile state-run tech forum in Shanghai this week after he was arrested last month in the U.S. on suspicion of rape.
TSLA

Hot Stocks

09:14 EDT Labaton files class action against Tesla on behalf of Citron's Andrew Left - Labaton Sucharow LLP announced that it has filed a securities class action lawsuit in San Francisco federal court on behalf of its client Andrew Left of Citron Research against Tesla and its CEO Elon Musk, alleging that Musk "artificially manipulated the price of Tesla stock" by taking to Twitter to announce fictional plans to take the publicly listed car company private. The complaint asserts claims on behalf of Tesla short-sellers forced to cover positions in response to Musk's market manipulation at a loss. The action also includes all investors that purchased Tesla shares at inflated prices and suffered losses after the truth behind Musk's supposedly 'secure' financing was exposed. Former federal prosecutor and Labaton Sucharow partner Michael Canty, who has been widely quoted by major news organizations, including CNBC, The New York Post and Reuters on the matter, states that Musk's tweets "appear to be a textbook case of securities fraud." The United States Securities and Exchange Commission has opened a formal inquiry into defendants' statements, and recently subpoenaed Defendants as they dig deeper into the "factual basis" of the going-private transaction.
ARMK

Hot Stocks

09:13 EDT Aramark to sell Healthcare Technologies for $300M to TRIMEDX - Aramark announced that it has signed a definitive agreement to sell its Healthcare Technologies, or HCT, business for $300M to TRIMEDX. Aramark's Healthcare Technologies business, based in Charlotte, NC, is a leading provider of healthcare technology services in North America, providing innovative management programs for clinical equipment at more than 500 hospital and healthcare facilities. The business, acquired by Aramark in 2001, has been in operation for over 45 years and employs more than 1,500 technicians, engineers and program staff. Services include maintenance and refurbishment of high end imaging equipment. "This transaction represents the latest step in our commitment to deliver sustainable shareholder value, while also increasing our financial flexibility," CEO Eric Foss added. "We will use the majority of proceeds to strengthen our balance sheet through debt reduction and will also repurchase $50 million of shares after closing of the sale."
AXON

Hot Stocks

09:11 EDT Roivant launches Respivant Sciences - Roivant Sciences announced the launch of Respivant Sciences, a biopharmaceutical company focused on improving the lives of patients suffering from serious respiratory diseases. Respivant will be led by CEO Bill Gerhart, Executive Vice President for Clinical and Regulatory Ahmet Tutuncu, MD, PhD, and Executive Vice President for Development and Manufacturing Pravin Soni, PhD. Respivant's pipeline is anchored by RVT-1601, an inhaled therapeutic being developed for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis. RVT-1601 is a mast cell stabilizer with pleotropic immune modulating properties delivered directly to the lungs via a handheld aerosol device that produces a soft mist for patients to conveniently inhale. In a Phase 2a clinical trial, RVT-1601 demonstrated a statistically significant reduction in cough frequency among IPF patients after 14 days of treatment. Respivant plans to initiate a Phase 2b study for RVT-1601 in the first quarter of 2019.
BAC

Hot Stocks

09:10 EDT Bank of America reports August card write-offs 2.75% vs. 2.57% last month - Reports August 30-plus day delinquencies 1.56% vs. 1.55% last month.
APHB

Hot Stocks

09:07 EDT AmpliPhi announces 'positive' FDA feedback for AB-SA01 - AmpliPhi Biosciences Corporation announced that the company had a Type B Pre-IND meeting with the U.S. Food and Drug Administration and has now received the meeting minutes. Based on the FDA's feedback, AmpliPhi currently plans to initiate the first randomized clinical trial of its AB-SA01 bacteriophage therapy product candidate in early 2019. The clinical trial is expected to enroll approximately 100 patients. AmpliPhi's wholly-owned GMP-certified manufacturing facility has the capacity to produce the company's proprietary bacteriophage therapeutics for the planned clinical trials, through an anticipated BLA filing and potential approval. The Type B Pre-IND meeting included discussion of the results from AmpliPhi's ongoing Expanded Access Program and the proposed design for two randomized, controlled clinical trials with AB-SA01, the company's clinical candidate targeting S. aureus, that were developed based on input from infectious disease physician thought leaders. The FDA was in general agreement with the proposed clinical trial designs: A Phase 1/2 randomized, controlled clinical trial to evaluate the safety and efficacy of AB-SA01, administered intravenously with the best available antibiotic therapy, compared to placebo plus best available antibiotic therapy, in approximately 100 patients with S. aureus bacteremia. A Phase 1/2 randomized, controlled clinical trial to evaluate the safety and efficacy of AB-SA01, administered by intra-articular injection and then intravenously with the best available antibiotic therapy, compared to placebo plus the best available antibiotic therapy, in approximately 100 patients with a hip or knee prosthetic joint infection due to S. aureus as an adjunct to surgical treatment. Importantly, based on the current FDA feedback, no additional clinical or nonclinical data are required to proceed with the two proposed randomized clinical trials. Furthermore, AmpliPhi continues to investigate if AB-SA01 may be eligible for Fast Track Designation and for approval under the Limited Population pathway, which is intended to facilitate development of therapeutics to treat serious or life-threatening infections in a limited population of patients with unmet need.
DEA

Hot Stocks

09:05 EDT Easterly Government Properties acquires eight properties for $244M - Easterly Government Properties announced that it has completed the acquisition of eight of the 14 properties in the company's previously announced portfolio acquisition. The eight properties represent an aggregate of 1,024,036 square feet and were acquired for a combined purchase price of $244M. The eight properties include: Various GSA - Buffalo, a 267,766-square foot multi-tenanted Class A office building completed in 2004, is primarily occupied by two federal agencies: the Department of Veterans Affairs and the Internal Revenue Service. Various GSA - Chicago, a multi-tenanted office building fully renovated in 1999, is strategically located next to Chicago O'Hare International Airport and serves as the Federal Aviation Administration's Great Lakes Regional Office, which oversees operations in eight states. TREAS - Parkersburg, a 182,500-square foot build-to-suit property, was built in multiple phases in 2004 and 2006 and is 100% leased to the General Services Administration for the beneficial use of the Bureau of Fiscal Service. SSA - Charleston, a 110,000-square foot single tenant facility fully renovated in 2000, is occupied by the Office of Hearings Operations, a part of the Social Security Administration. FBI - Pittsburgh serves as one of 56 FBI field offices located throughout the country. The 100,054-square foot facility was built-to-suit for the FBI in 2001 and is 100% leased. GSA - Clarksburg serves as a multi-tenanted federal center for various federal tenants within the market area, including the FBI, DEA, SSA, Offices of the U.S. Attorneys, and Small Business Association. This 100% leased 63,760-square foot build-to-suit facility was constructed in 1999 and serves the five tenant agencies through a single GSA lease. ICE - Pittsburgh, a state-of-the-art, build-to-suit facility constructed in 2004, is occupied by the U.S. Immigration and Customs Enforcement, which works to promote homeland security and public safety with respect to border control, customs, trade and immigration for the surrounding Pittsburgh region. SSA - Dallas is a 27,200-square foot build-to-suit facility 100% leased to the GSA for the beneficial use of the SSA. The company expects to complete the acquisition of the remaining six properties in the portfolio acquisition prior to the end of 2018.
MGP

Hot Stocks

09:04 EDT MGM Growth raises quarterly distribution to 43.75c per unit - MGM Growth Properties announced that MGM Growth Properties Operating Partnership LP declared a cash distribution to all unit holders of record, including MGP, on September 28, 2018 of 43.75c per unit for the third quarter. Simultaneously, MGP's board of directors declared a quarterly cash dividend of 43.75c per Class A common share for the third quarter. On an annualized basis, this dividend of $1.75 represents an increase of 7c per share year to date, for a total increase of 4.2%. This is the 5th dividend increase since MGP's initial public offering in April 2016. The dividends will be payable on October 15, 2018 to unit holders and shareholders of record as of the close of business on September 28, 2018, as applicable.
SCWX

Hot Stocks

09:04 EDT Secureworks enters strategic partnership with CrowdStrike - CrowdStrike and Secureworks announced at CrowdStrike's second annual user conference, Fal.Con, that they will bring a new level of advanced endpoint threat detection to the marketplace by teaming up to apply Secureworks' Red Cloak behavioral analytics and intelligence to CrowdStrike's Falcon platform data. The joint offering delivers in one package a market-leading endpoint detection and response solution with applied analytics and intelligence to accelerate investigations and provides guided remediation steps for more confident response to real threats.
FOX...

Hot Stocks

09:03 EDT Viet Dinh appointed Chief Legal and Policy Officer for new 'Fox' - Lachlan Murdoch, the future Chairman and CEO of new "Fox," the company to be spun-off in connection with the merger with The Walt Disney Company (DIS), announced the appointment of Viet D. Dinh as Fox's (FOX, FOXA) Chief Legal and Policy Officer. The appointment is effective immediately. Prior to his appointment, Mr. Dinh had stepped down from his role as independent director on the 21st Century Fox board
AGEN INCY

Hot Stocks

09:01 EDT Agenus receives $5M milestone payment from Incyte - Agenus (AGEN) announced receipt of a cash milestone from Incyte (INCY) for the initiation of a Phase 1 clinical trial of INCAGN2385, an anti-LAG-3 antibody discovered by Agenus. Based on this milestone and under the terms of the agreement, Agenus received a $5M payment and is eligible to receive up to an additional $505M in potential development, regulatory and commercial milestones from Incyte.
AMRS

Hot Stocks

09:00 EDT Amyris provides update on North Carolina facility - Amyris has monitored Hurricane Florence closely and provided an update on the safety of its employees and the condition of its Leland, NC production facility, which is used by Amyris's joint venture, Aprinnova. Power and connectivity remained lost in the local area, slowing efforts to communicate with employees. So far, nearly all have reported to be safe with family and loved ones. Following an initial assessment of the plant, the hurricane does not appear to have caused any material damage to the process equipment or the inventory. Assessments continue, but Amyris expects a quick return to full production once power is restored and the plant is back online. Amyris expects to resume full production of its squalane product for customers without any impact to its Q3 or full year squalane results. Customers including 2,000 of the world's leading skin care brands as well as Amyris's own Biossance brand will receive their needed supplies without interruption or any price change.
LAND

Hot Stocks

08:56 EDT Gladstone Land acquires two orchards in California for $6.9M - Gladstone Land announced that it has acquired two permanent crop farms totaling 194 gross acres in Kings County, California, for approximately $6.9M. In connection with the acquisition, the company and the seller entered into a 15-year, triple-net lease.
CLRB

Hot Stocks

08:55 EDT FDA grants RPDD to Cellectar Biosciences' CLR 131 - Cellectar Biosciences announced that the FDA has granted rare pediatric disease designation, or RPDD, to CLR 131 for the treatment of osteosarcoma, a rare pediatric cancer. CLR 131 is Cellectar's lead phospholipid drug conjugate product candidate.
SCHW

Hot Stocks

08:55 EDT Charles Schwab reports August core net new assets $20.8B - The Charles Schwab Corporation released its Monthly Activity Report. Company highlights for the month of August 2018 include: Core net new assets brought to the company by new and existing clients in August 2018 totaled $20.8B. Net new assets excluding mutual fund clearing totaled $18.6B. Total client assets were a record $3.56T as of month-end August, up 14% from August 2017 and up 2% compared to July 2018. New brokerage accounts totaled 132,000 in August, up 7% from August 2017 and up 12% compared to July 2018.
CPRT

Hot Stocks

08:54 EDT Copart opens second location in Germany - Copart is pleased to announce the opening of its second location in Germany. The facility is located at Industriegelande Nobitz 6, Nobitz, Thuringia, near Leipzig, Germany.
RARE GSK

Hot Stocks

08:47 EDT Ultragenyx appoints Wladimir Hogenhuis COO - Ultragenyx (RARE) announced that it has expanded its leadership team with the appointment of Wladimir Hogenhuis as COO, effective September 28. In this newly created role, Hogenhuis will oversee global commercial operations, business development and technical operations functions. He will report to Ultragenyx's CEO and will serve on the executive leadership team. Hogenhuis joins Ultragenyx from GlaxoSmithKline (GSK), where he most recently served as senior VP and GM, specialty franchise. Hogenhuis is a 24-year veteran of the pharmaceutical industry. He spent the last six years at GSK, where he was initially responsible for the company's cardiovascular, metabolic and neurosciences franchise.
MYND

Hot Stocks

08:47 EDT MYnd Analytics announces breakthrough device status for PEER 4.0 by FDA - MYnd Analytics announced that the U.S. FDA has granted Breakthrough Device designation for the company's next generation product PEER 4.0. PEER is the company's proprietary clinical phenotype database comprising over 40,000 medication outcomes for over 11,000 unique patients, which is used to predict how a patient will respond to a specific medication. The company's original product, now in its third generation, has been continuously registered as a class 1 MDDS since October 2011. George Carpenter, CEO of MYnd stated, "This breakthrough designation highlights the growing evidence from the Company, National Institute of Mental Health and independent researchers of the predictive capacity of EEG data when paired with our unique, proprietary PEER Registry. We appreciate the FDA's determination that PEER meets the requirements for this designation and are eager to work together with the FDA going forward."
MNLO

Hot Stocks

08:43 EDT Menlo Therapeutics initiates enrollment in second Phase 3 trial of serlopitant - Menlo Therapeutics announced it has initiated enrollment in the second of two Phase 3 trials of serlopitant for the treatment of pruritus with prurigo nodularis, or PN. This second PN Phase 3 trial is being conducted in Europe. In May, Menlo began enrollment in the first of the two PN Phase 3 trials which is being conducted in the U.S. The U.S. PN Phase 3 trial is more than 20% enrolled. Both PN Phase 3 trials are multi-center, randomized, double-blind, placebo-controlled trials intended to evaluate if treatment with 5 mg serlopitant daily for ten weeks can reduce pruritus associated with PN compared with placebo. Menlo expects to enroll 200 patients at approximately 50 sites in each trial. The trials are enrolling patients with a worst-itch NRS score, or WI-NRS, of at least seven at screening. The primary efficacy analysis for both of these trials is a four-point responder rate in the WI-NRS at ten weeks. Results from both trials are expected in the first half of 2020.
CVRR

Hot Stocks

08:40 EDT CVR Refining intends to sell crude oil tank farm in Oklahoma - CVR Refining announced that it intends to sell its Cushing, Oklahoma, crude oil tank farm and currently is entertaining bids from potential purchasers. The 1.5-million-barrel crude oil storage facility sits on approximately 130 acres and includes six storage tanks, each with the capacity to hold 250,000 barrels of crude oil. The property has sufficient acreage for approximately 12 additional tanks of similar size. The assets for sale include a truck unloading facility with one lease automatic custody transfer unit and four 400-barrel tanks. CVR Refining's Cushing tank farm provides ample connectivity to other Cushing terminals and pipelines. Located in central Oklahoma, Cushing is a major trading hub for crude oil and the delivery point for West Texas Intermediate crude oil, which is traded on the New York Mercantile Exchange.
SGBX

Hot Stocks

08:38 EDT SG Blocks announces new purchase order from U.S. Navy - SG Blocks expands its partnership with the U.S. Navy and receives a new purchase order to design and construct container-based modular offices representing an estimated revenue opportunity of $500,000 in 2018. The modules will be prefabricated offsite and delivered to the Georgia location by the end of 2018.
SGLB

Hot Stocks

08:38 EDT Sigma Labs sends letter to shareholders, regains Nasdaq compliance - Sigma Labs announced the release of the following letter to shareholders from chairman and CEO John Rice: "On Friday September 14th we announced that Mark Cola, our Co-founder, President, and CTO will be retiring from Sigma in October. Changes like this at the top of a company always prompt questions, concerns, and speculation, so I am writing you to simultaneously pay tribute to Mark along with providing assurance that your company's technology team is well structured and that the succession taking place is smooth and secure. Darren Beckett, Sigma's Vice President of Engineering, will assume Mark's internal management and technology responsibilities. Dr. Martin Piltch will step up to help fill Mark's role on the outside team of technology consultants. Both these men and I will be able to confer with Mark under a consulting contract being developed with Mark.A decade ago Mark Cola and Vivek Dave were among the co-founders of the technology company that became Sigma Labs. The new company's purpose was to develop and commercialize products based on advanced metallurgical science. As the startup evolved, the company developed three technologies: one dental, one munitions, and one in 3D metal manufacturing technology. Key people in the company came and went as the technologies were evolved, and as the corporate entity of Sigma evolved. In a transaction with an over-the-counter public company, Sigma Labs/B6 Sigma emerged as a public company narrowing its focus to 3D metal in-process-quality control technologies with Mark leading the effort as a CEO in charge of the developing the technology and doing everything else. Like most technology startups, leading Sigma to become a company with a commercially valuable effective technology was a really hard grind. Because of his determination, singular will, and tenacity, Mark bore the stresses of successfully engineering financings in the harsh reality of 'no financing, no company.' He persevered in the pursuit of a deep technological product which in the laboratory sometimes proves a method wrong and requires a restart. Starting with the founding metallurgical scientists, he recruited sophisticated software architects and code writers, cutting edge experts in algorithm development, a very senior scientist ex of Motorola and Intel with advanced statistical data analytics expertise, from his background at Los Alamos National Laboratory, he brought in a PhD Physicist (Dr. Piltch, above) expert in lasers and optics, from Intel he recruited the Vice President of Sigma's Engineering (V.P. Beckett above) with a background including charged particle accelerator technology, thermal devices, software development, advanced electronics and process engineering, and technology team management. To complement these product centered technologists, he added skilled applications engineers and hardware design/developers. And, there are more. We thank Mark as founder and a leader of Sigma Labs, for creating and driving a vision of advancing the Additive Manufacturing Industry's 'good' 3D manufacturing technology to become a 'great' high-quality manufacturing technology assured by Sigma's IPQA. We shareholders can thank Mark for building and leading the multi-discipline technology team that is commercializing our robust data-rich analytical and interactive software - hardware tools that promise to add real value to an industry that needs such a tool. Yes, Mark now surely has the right to step back. Thank you and well done, Mark Cola! Finally, in other developments. NASDAQ notified us that Sigma is again in compliance with Nasdaq's listing rule relating to sustaining the closing bid price of Sigma's common stock at or above $1 per share for at least 10 consecutive business days. Please visit our new website at www.sigmalabsinc.com, for this and all of our announcements."
TEUM

Hot Stocks

08:36 EDT Pareteum secures $50M in new contracts during August - Pareteum announced the signing of contracts totaling an additional $50M during the last two weeks of August 2018. These new contracts do not include any previously announced awarded contracts. The 36-Month Contractual Revenue Backlog totaled $375M at August 31, 2018.
SJW

Hot Stocks

08:36 EDT San Jose Water says 'working cooperatively' with CPUC investigation - San Jose Water Company, a wholly owned subsidiary of SJW Group, issued the following statement in response to the California Public Utilities Commission's recently issued Order Instituting Investigation 18-09-003 into San Jose Water's past billing practice used in implementing service charge rate changes: "We appreciate the effort and time of the CPUC in issuing its Order Instituting Investigation on September 14, 2018 regarding our past billing practice. As soon as SJW was informed about a potential billing issue in early 2017, we took immediate voluntary actions to investigate and review our billing policies, and we subsequently updated our billing practice to better serve our customers, with our new billing policies retroactively effective as of January 1, 2017. We also worked with the CPUC to propose refunds to our metered-service customers for the period from 2014 through 2016. We have since been working cooperatively with various departments at the CPUC to answer their questions about our past billing practice and potential remedial measures. While our past billing practice was in compliance with the rules as we interpreted them at that time, we also recognize that different interpretations may apply - and have since voluntarily updated our billing policies to reflect a more customer-oriented interpretation."
AXP

Hot Stocks

08:35 EDT American Express reports August net write-off rate 2.2% vs. 2.2% last month - Reports August 30 days past due loans 1.3% vs. 1.3% last month.
KOP

Hot Stocks

08:35 EDT Koppers Holdings announces repurchase of 684,788 shares - Koppers Holdings announced that it has repurchased 684,788 shares for approximately $24.1M under its share repurchase program authorized by its Board of Directors in November 2011. The shares were repurchased during the company's most recent open trading window, which commenced on August 13, 2018 and ended on September 7, 2018, at an average price of $35.20 per share. Approximately $24.8M of the original authorization of $75M remains after this latest activity.
XPO

Hot Stocks

08:34 EDT XPO Logistics says to add 8,000 seasonal jobs in North America - XPO Logistics announced that it expects to hire 8,000 North American logistics workers for the peak holiday season. The company's retail logistics volume through August is running approximately 20% higher than 2017, primarily driven by consumer demand for e-commerce and omnichannel retail fulfillment.
TBPH MYL

Hot Stocks

08:33 EDT Theravance Biopharma, Mylan report data from Phase 3 studies of YUPELRI - Theravance Biopharma (TBPH) and Mylan (MYL) announced that positive new data from the companies' Phase 3 clinical program for YUPELRI inhalation solution were featured in an oral presentation at the European Respiratory Society International Congress 2018, which is being held in Paris, France on September 15-19, 2018. Presented data showed reductions in the rates of chronic obstructive pulmonary disease exacerbations ranging from 15% to 18% in moderate to very severe COPD patients administered once-daily YUPELRI for up to 52 weeks as compared to placebo and tiotropium. While the YUPELRI Phase 3 program was not designed or powered to achieve statistical significance on differences in COPD exacerbation rates, researchers were interested in a post-hoc analysis of data from the studies to identify trends in this area. Researchers evaluated and presented data on COPD exacerbations that were collected from the three clinical trials comprising the Phase 3 YUPELRI program. Pooled data from the two replicate 12-week pivotal Phase 3 efficacy trials, which included a total of 1,229 patients with moderate to very severe COPD, demonstrated that the mean annualized rate of all COPD exacerbations was 0.47 for YUPELRI dosed at 175 mcg/day and 0.45 for YUPELRI dosed at 88 mcg/day. When compared to the mean annualized rate of exacerbations for placebo of 0.55, these results represent COPD exacerbation rate reductions in the range of 15% to 18%. Additionally, data from the 12-month Phase 3 safety trial, which included a total of 1,055 with moderate to very severe COPD, demonstrated that the estimated annualized rate of all COPD exacerbations was 0.38 for YUPELRI dosed at 175 mcg/day and 0.57 for YUPELRI dosed at 88 mcg/day, compared to 0.46 for tiotropium dosed at 18 mcg/day. These results for the 175 mcg/day YUPELRI dose represent a 17% reduction in COPD exacerbation rates as compared to tiotropium.
CONE

Hot Stocks

08:33 EDT CyrusOne names Mark Skomal SVP, chief accounting officer - CyrusOne announced the appointment of Mark Skomal as SVP and chief accounting officer, effective September 24, 2018. Skomal will report to Diane Morefield, EVP and CFO. Previously, Skomal was the SVP, chief accounting officer and controller for DCT Industrial Trust since 2007.
DSX

Hot Stocks

08:28 EDT Diana Shipping enters into time charter contract for m/v Artemis - Diana Shipping announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Ausca Shipping Limited, Hong Kong, for one of its Panamax dry bulk vessels, the Artemis. The gross charter rate is $12,600 per day, minus a 5% commission paid to third parties, for a period of minimum 12 months to maximum fifteen 15 months. The charter is expected to commence on September 18. The Artemis is currently chartered, as previously announced, at a gross charter rate of $9,000 per day, minus a 5% commission paid to third parties. This employment is anticipated to generate approximately $4.54M of gross revenue for the minimum scheduled period of the time charter.
PLYA HLT

Hot Stocks

08:24 EDT Playa Hotels & Resorts, Hilton announce alliance - Playa Hotels & Resorts (PLYA) and Hilton (HLT) announced plans to leverage Playa Hotels & Resorts' all-inclusive expertise with Hilton's global portfolio of brands, and over 78M participating members in Hilton Honors, Hilton's award-winning loyalty program, to accelerate the growth of Hilton's all-inclusive resorts. As part of the alliance, by the end of 2018, two Playa resorts, The Royal Playa del Carmen, and the Dreams La Romana, will be converted to Hilton all-inclusive resorts, with the potential for the conversion and management of eight additional resorts by 2025. The converted properties will allow guests to earn and redeem points through Hilton Honors. Although we anticipate some initial disruption, strategic alliances with world class partners such as Hilton can be transformative for Playa in the long-run. As a result of rebranding and renovations, as well as competitive discounting among our peers in Playa del Carmen and Cancun, at the midpoint, we currently expect our 2018 and 2019 EBITDA outlooks to decrease by $4.5 M and $26M, respectively.
MNGA

Hot Stocks

08:19 EDT MagneGas completes independent safety testing for MagneGas2 - MagneGas announced that the company has conducted a series of independent safety tests with multiple, independent third-party safety and engineering firms to further validate the company's safety claims regarding MagneGas2 compared to acetylene. The tests were highly favorable and support the company's claims that MagneGas2 is a stable, safer alternative to acetylene, the most widely-used metal cutting fuel used globally. The company engaged DEKRA, a leading global safety firm in operations to conduct two safety tests. First, DEKRA conducted three 10-minute minimum horizontal vibration tests. These tests simulate the real-world transportation of gas cylinders and is designed to deliberately agitate the cylinder's contents evaluating their stability for their safe handling. The agitated cylinders were then used in subsequent tests. Next, DEKRA conducted an industry standard 12-meter drop test that involved the free fall drop of an industrial gas cylinder onto a concrete pad with a steel plate cover. The primary purpose of this drop test is to gauge the stability of the cylinder contents to extreme external shock. DEKRA conducted a total of nine 12-meter drop tests on cylinders filled at 100%, 60%, and 20% fill levels of MagneGas2. In all instances, MagneGas2 contents remained completely stable with no explosions, fires, or evidence of instability.
CAJ NFLX

Hot Stocks

08:18 EDT Canon U.S.A. joins Netflix's new Post Technology Alliance - Canon U.S.A. (CAJ) is proud to announce the company will be joining Netflix's (NFLX) brand-new Post Technology Alliance, which brings together industry leaders committed to working closely with Netflix to innovate production workflows and support creatives globally. As a part of the Post Technology Alliance program, products receive the Post Technology Alliance designation logo - a mark of quality, service, and support. The logo signals that a product meets Netflix technical and delivery specifications and will continue to do so in the future.
AFL

Hot Stocks

08:16 EDT Aflac raises investment in Aflac Ventures Fund to $250M from $100M - Aflac announced that as part of its overall corporate venture strategy, the company is increasing its original investment in the Aflac Ventures Fund from $100M over three years to $250M over three to four years, as opportunities emerge. To date, the Aflac Ventures Fund has made eight investments in mainly early-stage companies both in Japan and the U.S., with individual investment size ranging from $1M to $6M and ownership stakes from 3% to 14%. In addition to equity investments, in most cases Aflac U.S. and Aflac Japan maintain commercial relationships with target companies in support of mutual growth initiatives.
INAP

Hot Stocks

08:15 EDT Internap subsidiary renews agreement with Canadian pension investment manager - Internap and one of Canada's largest pension investment managers, announced a multi-year colocation deal in INAP's Tier 3 design Montreal data center. This financial services customer handles some of the largest Canadian public entities and renewed their relationship with iWeb based on a successful 5-year track record of meeting all requirements. Under terms of the deal, iWeb will provide robust connectivity, guaranteed 100% power uptime and network access, all within a high-density green environment.
NVEE

Hot Stocks

08:12 EDT NV5 Global receives $5M services contract - NV5 Global announced that it has been selected to provide general engineering design services, including civil design, geotechnical engineering, field and aerial surveying, and environmental planning for the New Jersey Department of Transportation. The contract totals $5M in fees over three years.
CRSP

Hot Stocks

08:10 EDT Crispr Therapeutics, ViaCyte announce collaboration on diabetes treatment - Crispr Therapeutics and ViaCyte announced a collaboration focused on the discovery, development, and commercialization of gene-edited allogeneic stem cell therapies for the treatment of diabetes. Decades of clinical data with islet transplants indicate that beta-cell replacement approaches may offer curative benefit to patients with insulin-requiring diabetes. ViaCyte has pioneered the approach of generating pancreatic-lineage cells from stem cells and delivering them safely and efficiently to patients. PEC-Direct, ViaCyte's lead product candidate currently being evaluated in the clinic, uses a non-immunoprotective delivery device that permits direct vascularization of the cell therapy. This approach has the potential to deliver durable benefit; however, because the patient's immune system will identify these cells as foreign, PEC-Direct will require long-term immunosuppression to avoid rejection. As a result, PEC-Direct is being developed as a therapy for the subset of patients with type 1 diabetes at high risk for acute complications. Crispr gene editing offers the potential to protect the transplanted cells from the patient's immune system by ex vivo editing immune-modulatory genes within the stem cell line used to produce the pancreatic-lineage cells. Crispr Therapeutics is pursuing a similar approach for its allogeneic CAR-T programs and has established significant expertise in immune-evasive gene editing. The combination of ViaCyte's stem cell capabilities and Crispr's gene editing capabilities has the potential to enable a beta-cell replacement product that may deliver durable benefit to patients without triggering an immune reaction. Under the terms of the agreement, Crispr and ViaCyte will jointly seek to develop an immune-evasive stem cell line as a first step on the path to an allogeneic stem-cell derived product. Upon successful completion of these studies and identification of a product candidate, the parties will jointly assume responsibility for further development and commercialization worldwide. Upon execution of the agreement ViaCyte will receive $15M from Crispr, which at Crispr's election may be paid in either cash or Crispr stock. ViaCyte also has the option, under certain circumstances, to receive an additional $10M from Crispr in the form of a convertible promissory note.
ARCI

Hot Stocks

08:09 EDT Appliance Recycling unit enters agreement with software engineering firm - Appliance Recycling announced that its subsidiary, GeoTraq, has recently entered into an agreement with a software engineering firm specializing in secure software architecture to design a scalable Internet of Things device management platform capable of securely managing millions of IoT devices deployed throughout the world using GeoTraq's proprietary Cell-ID technology. GeoTraq intends to manufacture a cellular IoT module that is designed to support hundreds of vertical markets and thousands of applications. GeoTraq expects that businesses will ultimately be able to deploy GeoTraq powered IoT devices throughout the world for far less cost and complexity than other IoT solutions currently available on the market. GeoTraq expects to offer the simplest global IoT solution on the market.
ETFC

Hot Stocks

08:09 EDT E-Trade reports August DARTs up 30% y/y - E*TRADE Financial Corporation released its Monthly Activity Report for August 2018. Daily Average Revenue Trades for August were 267,619, a 7% increase from July and a 30% increase from the year-ago period. Derivatives represented 32% of DARTs during the month. The company added 58,119 gross new brokerage accounts in August and ended the month with approximately 3.9M brokerage accounts-an increase of 32,973 from July. Net new brokerage assets were $1.7B in the month. During the month, customer security holdings increased by $17.8B, and brokerage-related cash increased by $1.2B to $53.5B. Customer margin balances decreased $0.3B, ending the month at $10.7B. Customers were net sellers of approximately $0.3B in securities during the month.
USAU

Hot Stocks

08:08 EDT U.S. Gold says Plan of Operation for Keystone Project approved - U.S. Gold reported that its Plan of Operation for its 100%-owned Keystone Project on Nevada's Cortez Gold Trend has been approved by the U.S. Federal Government's Department of Interior, Bureau of Land Management. The decision letter is available at: Keystone_Decision. With this approval, U.S. Gold Corp. can now access and drill almost all localities of BLM managed public lands within the 20 square mile Keystone Project area.
SYY

Hot Stocks

08:06 EDT Sysco names CEO Tom Bene as chairman, announces retirement of Jackie Ward - Sysco Corporation announced that, in alignment with Sysco's board of directors' tenure policy, Jackie M. Ward will retire from the company's board after more than 17 years of service, including the last five years as non-executive chairman. Ward's retirement is part of Sysco's board succession plan and will be effective on November 16, immediately following Sysco's 2018 Annual Meeting of Stockholders. Tom Bene, Sysco's president and CEO, has been elected chairman of the board, effective upon Ward's retirement. "After careful deliberation, and taking into account his record of success to date in driving Sysco to achieve its strategic objectives, the board determined that naming Tom to succeed Jackie as chairman was in the best interest of the company and its shareholders," said Larry Glasscock, Sysco director and chair of the corporate governance and nominating committee. "We are confident that Sysco is well-positioned under Tom's leadership for continued success and value creation." Sysco's board intends to appoint an independent lead director prior to the 2018 annual meeting.
SPLK

Hot Stocks

08:06 EDT Splunk appoints Jake Loomis as Chief Digital Officer - Splunk (SPLK) announced it has appointed Jake Loomis as senior vice president, Chief Digital Officer. Loomis will oversee the digital transformation strategy at Splunk, specifically focused on the IT and Information Security space. Loomis previously served more than two years as Engineering Director, Internet Services Operations group at Apple (AAPL), responsible for engineering and operations support for most of its global cloud customers.
CFMS

Hot Stocks

08:05 EDT Conformis settles patent disputes with Smith & Nephew, will receive $10.5M - Conformis announced that it has entered into a settlement and license agreement with Smith & Nephew that resolves all patent disputes between Conformis and Smith & Nephew. Pursuant to the agreement, Smith & Nephew is required to pay $10.5M to Conformis, and the parties have entered into a limited patent cross-license.
HALO RHHBY

Hot Stocks

08:05 EDT Halozyme: Roche receives approval for subcutaneous formulation of trastuzumab - Halozyme (HALO) announced that Roche (RHHBY) has received approval from Health Canada for a subcutaneous formulation of trastuzumab for the treatment of patients with HER2-positive breast cancer. This is a co-formulation with Halozyme's proprietary recombinant human hyaluronidase enzyme.
APHB

Hot Stocks

08:05 EDT AmpliPhi announces 'positive' clinical results for expanded access program - AmpliPhi Biosciences Corporation announced updated topline clinical results for its ongoing single-patient expanded access program. 84% of patients achieved treatment success at the end of therapy, defined as complete resolution or significant improvement of baseline signs and symptoms. AmpliPhi has now provided its investigational bacteriophage therapeutics for a total of 21 patients, at 7 hospitals, with serious or life-threatening infections not responding to antibiotic therapy. These patients were treated with AB-SA01 or AB-PA01 under single-patient expanded access programs in the U.S. or Australia. The following analysis updates the data previously announced by the company on January 3, 2018: 15 patients with serious S. aureus infections were treated with AB-SA01 and 6 patients with serious P. aeruginosa infections were treated with AB-PA01. Infections in the treated patients included bacteremia, native and prosthetic valve endocarditis, recurrent pneumonia, ventilator-associated pneumonia, prosthetic joint infection, ventricular assist device infection, and others. Over 1,000 bacteriophage doses were administered as part of the expanded access program including: 400+ doses of AB-SA01, including 300+ doses administered intravenously. Treatment was well-tolerated in all patients with no treatment related serious adverse events. 600+ doses of AB-PA01, including 400+ doses administered intravenously. Treatment was well-tolerated in five patients. One patient discontinued treatment due to Grade 1 and 2 adverse events, which resolved within 18 hours. There were no treatment-related SAEs. 84% of patients in the modified intent-to-treat population achieved treatment success at the end of therapy. Treatment success, as determined by the treating physician, was defined as a complete resolution or significant improvement of baseline signs and symptoms. mITT population was defined as all patients who met the criteria for clinical diagnosis, whose bacterial isolate was susceptible to phage and who received at least one dose of phage.
ALK

Hot Stocks

08:03 EDT Alaska Air reports August traffic up 3.8%, capacity up 4.3% - On a combined basis for all operations, Air Group reported a 3.8% increase in traffic on a 4.3% increase in capacity compared to August 2017. Load factor decreased 0.5 points to 85.7%.
THC

Hot Stocks

08:02 EDT Tenet hospitals in South Carolina fully operational after Hurricane Florence - Tenet Healthcare announced that its four hospitals in South Carolina are fully operational following Hurricane Florence and meeting the healthcare needs of the communities they serve. Coastal Carolina Hospital, East Cooper Medical Center and Hilton Head Hospital, which are all located in areas impacted by the storm, had no material damage. These hospitals resumed normal operations over the weekend, and it is noteworthy that they remained open during the storm. East Cooper Medical Center in Mt. Pleasant, S.C., received an exception to the mandatory evacuation order issued by the Governor of South Carolina and remained open with reduced census and an operational emergency room. Piedmont Medical Center was not directly impacted by the storm and remained fully operational. USPI has eight surgery centers in areas impacted by the storm. Those facilities are in the process of rescheduling cancelled cases, with plans in place to be operational as of today.
PFE

Hot Stocks

08:02 EDT Atomwise, Pfizer enter into an evaluation agreement - Atomwise has entered into an evaluation agreement with Pfizer. Pfizer will evaluate Atomwise's platform to identify potential drug candidates for up to three target proteins selected by Pfizer. In the agreement, Pfizer will pay a technology access fee and additional success-based payments for each target protein of interest. Atomwise will computationally analyze millions of diverse small molecules for each of Pfizer's identified target proteins using its cutting-edge AI platform to predict those that may bind with high affinity to the selected target proteins. Atomwise's medicinal and computational chemistry teams will also work with Pfizer scientists to define the required potency and other chemical properties of the small molecules for the targets of interest.
TEL

Hot Stocks

08:02 EDT Cerberus to acquire Subsea Communications business from TE Connectivity - Cerberus Capital Management announced that one of its affiliates has entered into an agreement with TE Connectivity Ltd. under which Cerberus will acquire TE's Subsea Communications business. Headquartered in Eatontown, New Jersey, SubCom is a leading global supplier of subsea communications systems with approximately $700M in revenue, based on fiscal year 2018 expectations. The business designs, manufactures, deploys, and maintains the subsea fiber optic cable systems that are vital for global communications. To date, SubCom has completed more than 100 cable systems and deployed over 610,000 kilometers of cable through its eight high-performance cable ships, which are among the most efficient and capable in the industry. SubCom, supported by approximately 1,400 employees, has a strong customer base of leading internet content providers, telecommunications companies, and entrepreneurs around the world.The transaction is subject to customary closing conditions and is expected to close in the fourth quarter of 2018.
KMPH

Hot Stocks

07:45 EDT KemPharm announces topline results from IN HAP trial of serdexmethylphenidate - KemPharm announced topline results from its intranasal, or IN, human abuse potential, or HAP, clinical trial of serdexmethylphenidate, the major active pharmaceutical ingredient in KP415, KemPharm's investigational product candidate for the treatment of ADHD. In the IN HAP trial, SDX produced significantly lower scores on the primary endpoint, maximal drug liking, and other abuse-related endpoints, compared to intranasal d-methylphenidate hydrochloride, indicating that SDX is not efficiently converted to active d-methylphenidate when snorted. KemPharm will present the data from all three HAP trials, as well as tampering study results, to the FDA as part of its human abuse potential assessment for SDX in the KP415 new drug application, or NDA. During the review process, the FDA will recommend a controlled substance schedule for SDX to the Drug Enforcement Agency, or DEA. If KP415 is approved, the DEA must subsequently confirm the schedule for SDX, and KemPharm believes that the entirety of the data may support a lower schedule compared to other currently available methylphenidate-based ADHD products. Furthermore, since the FDA has required KemPharm to conduct all three HAP trials, KemPharm anticipates that data from these trials may likely be included in the label.
SECO

Hot Stocks

07:42 EDT Seeco Holding announces partnership with Feelunique - Secoo is pleased to announce a partnership with Feelunique, Europe's leading online beauty retailer, to launch a dedicated Feelunique-branded cosmetics store within Secoo's platform in next months. Through this unique partnership, Feelunique will provide Secoo's sophisticated Chinese customer base of more than 20 million high net-worth members with access to highly sought-after premium and niche international beauty brands. The store will launch in Q4 2018, building out Secoo's cosmetics category and providing an additional potent channel for Feelunique to serve China's fast-growing online beauty market. Orders placed through the Feelunique store on Secoo will be fulfilled by Feelunique's strategically located distribution hub in Hong Kong, due to be operational next month. Secoo and Feelunique will jointly create high-quality editorial content to inform and inspire consumers, in-line with Feelunique's highly successful content - and community - led strategy. All pricing, promotions, merchandising and inventory will be managed by Feelunique.
WAB GE

Hot Stocks

07:41 EDT Wabtec files proxy statement with SEC relating to GE Transportation combination - Wabtec (WAB) filed an amended preliminary proxy statement with the SEC relating to its proposed combination with GE (GE) Transportation. Wabtec and GE Transportation are progressing the proposed transaction toward an anticipated closing by Q1. The amended preliminary proxy statement includes a minor adjustment to harmonize GE Transportation's historical financial information with Wabtec's revenue recognition accounting policies for the purpose of the preparation of required pro forma financial statements. This harmonization is expected to result in a $63M decrease in forecasted combined consolidated net revenue and EBIT in 2019, with no material effect in future years. The accounting policy harmonization does not materially affect Wabtec's future reported consolidated cash from operations. As is common in transactions of this nature, other adjustments may be required to conform to Wabtec's accounting policies, but they are not expected to be material. In addition, non-cash amortization expense from purchase price accounting will impact the results of operations.
MGM...

Hot Stocks

07:41 EDT Macau casino revenue estimate cut as typhoon shutters operations - Over the weekend, Macau's government decided to suspend all casino operations starting on Saturday, September 15, due to safety concerns ahead of Typhoon Mangkhut, which has already left devastation in the Philippines and is now making its way across southern China. JPMorgan analyst DS Kim said he believes this to be the first time in Macau's recent history that the government has ordered the blanket suspension of all casino operations. He thinks business will be negatively impacted at least until early next week and "guestimates" the negative impact from Mangkhut could amount to roughly 8%-10% of September gross gaming revenue. Kim now forecasts September gross gaming revenue to grow low-single-digits, which is down from his prior estimate of over 13% and compares to the pre-typhoon consensus estimates of low-to-mid-teens percentage year-over-year growth. Publicly traded companies in the Macau gaming space include Las Vegas Sands (LVS), MGM Resorts (MGM), Wynn Resorts (WYNN) and Melco Resorts (MLCO).
TSN

Hot Stocks

07:34 EDT Tyson Foods CEO Tom Hayes to step down, Noel White to succeed - Tyson Foods announced its board has appointed Noel White, formerly group president of beef, pork and international and a member of Tyson Foods' enterprise leadership team, as president and CEO, effective September 30. White, who will also join the board of directors, will succeed Tom Hayes, who is stepping down for personal reasons. White has over 30 years of experience in the food industry and worked at IBP for nearly two decades prior to its 2001 acquisition by Tyson Foods.
MRSN

Hot Stocks

07:32 EDT Mersana Therapeutics trading resumes
ADS

Hot Stocks

07:30 EDT Alliance Data reports August net charge offs 5.8% vs. 5.9% last month - Reports August delinquency rate 5.6% vs. 5.7% last month.
RLM

Hot Stocks

07:30 EDT Realm Therapeutics PLC (ADS) trading resumes
PLAY

Hot Stocks

07:26 EDT Dave & Buster's initiated quarterly dividend of 15c per share - As part of its Q2 earnings release on Friday, Dave & Buster's also initiated a 15c per share dividend, payable on October 10, 2018 to shareholders of record on September 25, 2018.
TEVA

Hot Stocks

07:15 EDT Teva up 6.9% to $24.43 after FDA approves AJOVYTM injection - Also this morning, Mizuho analyst Irina Koffler raised her price target for Teva Pharmaceutical to $29 from $28. In pre-market trading, shares of Teva are up 6.9% to $24.43.
QRHC

Hot Stocks

07:15 EDT Quest Resource launches natural disaster waste management recovery program - Quest Resource announced the launch of a natural disaster waste management recovery program that quickly responds to catastrophic events and provides emergency cleanup services across the United States. Quest tracks incoming storms and leverages its network of subcontractors to deploy debris removal solutions, hazardous waste treatment and cleanup services to help its customers and participating affected communities quickly recover from the natural disaster and rebuild their operations.
MRSN

Hot Stocks

07:12 EDT Mersana Therapeutics announces FDA lifts partial clinical hold on XMT-1522 - Mersana Therapeutics announced that the FDA has lifted the partial clinical hold on the Phase 1 study of XMT-1522. Mersana and the FDA reached alignment on changes to the protocol, including increased monitoring as well as the exclusion of patients with advanced hepatic impairment. Although XMT-1536, Mersana's Dolaflexin ADC targeting NaPi2b, was not subject to a clinical hold, Mersana has decided to implement similar modifications to the XMT-1536 protocol. In addition, alternative dosing regimens will be evaluated for both clinical trials.The XMT-1522 trial will begin with a once-every-four-week dose regimen. This dosing regimen has already been implemented in the XMT-1536 trial at previously explored dose levels in order to enable a comparison of relevant doses and their impact on the safety, efficacy and PK profile of the drug candidate. The company may evaluate additional regimens as well. Data on XMT-1536 is expected in the first half of 2019.
BABY EXTR

Hot Stocks

07:09 EDT Natus Medical appoints Drew Davies CFO - Natus Medical (BABY) announced the appointment of Drew Davies as executive VP and CFO, effective October 1. Davies brings nearly 30 years of financial and operational experience to Natus. Sharon Villaverde, who has served as interim CFO since July 11, will continue in her role as VP of finance. Davies most recently served as executive VP and CFO of Extreme Networks (EXTR).
SVA

Hot Stocks

07:06 EDT Sinovac Biotech says DOJ closes investigation, no charges filed - Sinovac Biotech announced that the U.S. Department of Justice has closed its investigation, with no charges, into possible violations of the Foreign Corrupt Practices Act related to allegations that certain Sinovac employees made improper payments to Chinese government officials. The closing of the DOJ investigation follows the SEC's termination of its related investigation, which the company announced on August 20, 2018. With the closure of the DOJ's investigation, the company is not aware of any pending U.S. government investigations of the company related to these matters. Sinovac is committed to conducting business in compliance with all applicable laws and cooperated fully with the DOJ. Sinovac will continue in its mission of researching, developing, manufacturing and commercializing vaccines that protect against human infectious diseases.
BCRX

Hot Stocks

07:05 EDT BioCryst receives $3.5M contract amendment from NIAID for galidesivir - BioCryst announced that the National Institute of Allergy and Infectious Diseases, or NIAID, part of the National Institutes of Health, has awarded BioCryst an additional $3.5M to support clinical trials of galidesivir in patients with yellow fever. Yellow fever represents a significant unmet medical need and a new potential use of galidesivir. With this additional $3.5M contract amendment, the NIAID development contract for galidesivir now totals $43M. BioCryst has global rights to galidesivir, a broad-spectrum antiviral drug in development for the treatment of Marburg and Ebola viral diseases. In a phase 1 trial of clinical safety and pharmacokinetics in healthy subjects, galidesivir was safe and well tolerated. In animal studies, galidesivir also has demonstrated survival benefits against Marburg, Ebola, yellow fever and Zika viruses. With the additional NIAID funding, BioCryst plans to assess the safety, tolerability, pharmacokinetics and effectiveness of galidesivir in human subjects with yellow fever, and to determine a safe and effective dose for further evaluation of galidesivir in Marburg or Ebola infection.
NEPT

Hot Stocks

07:04 EDT Neptune Technologies gets Confirmation of Readiness letter from Health Canada - Neptune Technologies announced that it has received a Confirmation of Readiness letter from Health Canada in regard to its application to become a Licensed Producer under the ACMPR. Health Canada's positive response marks another important regulatory step forward to obtaining Neptune's licence to produce cannabis oil supporting our timeline to commence commercialization this fiscal year. Neptune will notify Health Canada in the coming days and provide all additional required evidence to the agency to demonstrate the Corporation's readiness to commence production. Upon satisfactory review by Health Canada of any additional information submitted by Neptune, the Corporation would receive its licence for cannabis extraction.
ACN

Hot Stocks

07:02 EDT Accenture Federal Services awarded position on SEC ONE IT contract - Accenture announced that the U.S. Securities and Exchange Commission has awarded Accenture Federal Services a position on the ONE IT contract - a multiple-award, indefinite delivery / indefinite quantity contract with a total estimated value of $2.5B. A strategic sourcing vehicle with a five-year performance period and a five-year extension option, ONE IT allows the SEC to acquire integrated IT solutions for its evolving business needs, including leading-edge or emerging IT services that support mission-critical systems and software development across a variety of environments and infrastructures
SHOO

Hot Stocks

07:01 EDT Steven Madden announces 3-for-2 stock split - Steve Madden announced that its Board of Directors has declared a three-for-two stock split, in the form of a stock dividend, of the company's outstanding shares of common stock. The stock split will entitle all stockholders of record at the close of business on October 1, 2018, to receive one additional share of Steve Madden common stock for every two shares of common stock held on that date. The additional shares are expected to be distributed to stockholders on or about October 11, 2018, by the company's transfer agent. As a result of the stock split, the number of outstanding shares of the company's common stock will increase to approximately 87.6M shares from approximately 58.4M shares outstanding prior to the split.
ASLN

Hot Stocks

06:59 EDT Aslan Pharmaceuticals updates timeline for trial of varlitinib plus capecitabine - ASLAN Pharmaceuticals announced an update to its planned timelines for the ongoing single-arm clinical trial in China testing varlitinib plus capecitabine in patients with advanced or metastatic biliary tract cancer. The open-label study planned to enrol 68 patients with BTC who had progressed on at least one line of prior chemotherapy. Based on a review of patients recruited to-date and discussions with key investigators, it was agreed that a protocol amendment should be submitted to local authorities to modify enrolment criteria and to ensure the study will provide an accurate evaluation of varlitinib's efficacy. Review and implementation of the voluntary amendment is expected to take approximately 4 months. In the interim, ASLAN will continue to recruit patients into the study and provide a further update on study timelines in early 2019. ASLAN's global pivotal study in second line BTC, TREETOPP, remains on track to complete patient enrolment in early 2019. TREETOPP is a randomised, double-blind, placebo-controlled clinical trial in second line BTC comparing varlitinib and capecitabine to placebo and capecitabine. If positive, data from the TREETOPP study will be used in regulatory approval submissions for varlitinib globally. Patients enrolled into the second line study in China appear to have performed significantly worse, prior to recruitment, in the first line setting than observed in published global studies. In the first 27 patients enrolled, the first line response rate was approximately 7% and progression free survival (PFS) was 2.7 months. In comparison, the ABC-021 study that compared cisplatin plus gemcitabine to gemcitabine alone, the current standard of care for first line treatment of patients with advanced BTC, showed a first line response rate of 26% and PFS of 8 months for patients on cisplatin and gemcitabine. In the 14 patients that received a 6-week scan in the study, 1 partial response and 6 patients with stable disease were reported based on site assessment. For the same 14 patients in the first line setting, there were 2 partial responses and 4 patients with stable disease.
RLM

Hot Stocks

06:55 EDT Realm Therapeutics PLC (ADS) trading halted, news pending
MRSN

Hot Stocks

06:55 EDT Mersana Therapeutics trading halted, news pending
JPM

Hot Stocks

06:55 EDT JPMorgan reports August net credit losses 2.36% vs. 2.30% last month - Reports August 30-plus day delinquencies 1.10% vs. 1.10% last month.
SYF

Hot Stocks

06:47 EDT Synchrony reports August net charge-offs 4.81% vs. 5.01% last month - Reports August 30-plus day delinquencies 2.74% vs. 2.70% last month.
LEU

Hot Stocks

06:46 EDT Centrus Energy Doosan sign Memorandum of Understanding - Centrus Energy and Doosan Heavy Industries and Construction Co. announced a Memorandum of Understanding to explore opportunities to cooperate in providing manufacturing, engineering and technical services and goods to the nuclear industry - including advanced technologies that will be utilized in the next generation of commercial nuclear reactors under development around the world. The MOU establishes a framework for Centrus and Doosan to explore a range of commercial initiatives that would take advantage of the unique technical capabilities, expertise, and customer relationships of both companies. In particular, Centrus and Doosan plan to pursue opportunities for cooperation in serving the companies developing the next generation of nuclear reactors, which will require advanced engineering and manufacturing capabilities and innovative fuel designs.
BC

Hot Stocks

06:41 EDT Brunswick division partners with Dealer Spike to enhance online presence - Dealer Spike has agreed to a partnership with Mercury Marine, a division of Brunswick, to enhance the online presence of Mercury-authorized dealerships in the United States. Mercury's dealer partners will now have the opportunity to upgrade to custom websites in the industry with top-of-the-line marketing services. As Dealer Spike clients, Mercury-authorized dealers will have access to imagery for product releases and spec data for all inventory units, integrated to keep every website completely up to date. Customer solutions agents are accessible to provide assistance associated with online showrooms. Dealer Spike's experts provide consultation and advice to help dealers best advertise businesses online. In addition, dealerships will gain access to co-op opportunities offered through Mercury Marine. administrative abilities on the back-end of Dealer Spike websites to access for those dealers who prefer hands-on management. Dealer Spike also offers pay-per-click advertising, marketing automation, advanced search engine optimization strategies, and a full suite of online advertising tools.
CDXC

Hot Stocks

06:31 EDT ChromaDex announces partnership with Jiangxi Government in China - ChromaDex announced a strategic partnership for healthy aging research with the Jiangxi Provincial Government, People's Republic of China. The initiative will allow Jiangxi to become a foothold for advanced scientific research and business development to solve the problem of aging. The parties continue to discuss the details of the relationship, including their respective contributions to the venture, with the anticipation of finalizing definitive agreements later this year. In addition to the anti-aging initiative, the ceremony also celebrated the launch of the Food Technology Science Park, in collaboration with Qifeng Food Technology Co. of Beijing, to build a world-class, tech-centric science research complex in Jiangxi.
MSFT

Hot Stocks

06:18 EDT EU antitrust ruling on Microsoft buy of GitHub due by October 19 - EU antitrust regulators will decide by October 19 whether to clear Microsoft's proposed $7.5B acquisition of GitHub, the European Commission said on its website.
MESO

Hot Stocks

06:16 EDT Tasly obtains all necessary approvals for transaction with Mesoblast - Mesoblast announced that Tasly Pharmaceutical Group has successfully obtained all necessary approvals, including the Safe Administration of Foreign Exchange, required for closing the investment agreement and the development and collaboration agreement with Mesoblast to commercialize cell therapies for cardiovascular diseases in China.
TSLA

Hot Stocks

06:15 EDT Musk: Tesla has gone from 'production hell' to 'delivery logistics hell' - In response to a customer complaint on delivery delay, Tesla CEO Elon Musk tweeted on Sunday: "Sorry, we've gone from production hell to delivery logistics hell, but this problem is far more tractable. We're making rapid progress. Should be solved shortly." Reference Link
COF

Hot Stocks

06:14 EDT Capital One reports August net charge-offs 4.54% vs. 4.39% last month - Reports August 30-plus day performing delinquencies 3.58% vs. 3.46% last month.
HJLI

Hot Stocks

06:11 EDT Study confirms significant potential U.S. Market for Hancock Jaffe's VenoValve - Hancock Jaffe Laboratories has commissioned a research report from The Sage Group, a research organization specializing in peripheral vascular disease. The report, titled "Chronic Venous Disease: Epidemiology and Economics" analyzes the size of the addressable market for HJLI's VenoValve, as well as the economic burden of Chronic Venous Insufficiency. The study identifies the total number of CVI sufferers in the U.S. as 22.6M, including 3.1M new diagnoses each year. The U.S. economic burden of venous ulcers from CVI is estimated to be $38B a year. The report looks at the prevalence in the U.S. of other chronic diseases such as Alzheimer's, Stroke, Cancer, Coronary Heart Disease, Peripheral Artery Disease, and Diabetes and compares them to CVI. According to the author of the report, Mary Yost, "CVI affects twice as many people as all cardio vascular diseases combined, and 6 times more than diabetes. It is one of our most prevalent diseases. However, CVI is significantly underestimated, under diagnosed, and under treated." The report goes on to look at the number of annual procedures for common cardiac and vascular devices and ailments such as heart valves, ventricle assist devices, abdominal aortic aneurysms, cardio defibrillators, and pacemakers. The range of procedures includes ventricle assist devices with approximately 4,000 procedures a year at the low end, and pacemakers at 200,000 procedures a year at the high end. With an addressable market of approximately 4.5M CVI sufferers, the VenoValve has the potential to equal or exceed the most commonly implanted medical devices.
RDS.A RDS.B

Hot Stocks

06:10 EDT Shell aims to maintain methane emissions intensity below 0.2% by 2025 - Royal Dutch Shell announced a target to maintain methane emissions intensity below 0.2% by 2025. This target covers all oil and gas assets for which Shell is the operator. "This methane target complements Shell's ambition to cut the Net Carbon Footprint of our energy products by around half by 2050, which we announced in November 2017," said Maarten Wetselaar, Shell's Integrated Gas & New Energies Director. "It is a further demonstration of our continued focus on tackling greenhouse gas emissions. Such efforts are a critical part of Shell's strategy to thrive during the global energy transition by providing more and cleaner energy." To maintain this methane target, Shell is implementing programs, including using infrared cameras to scan for methane emissions, deploying advanced technology to repair leaks, and replacing high-bleed pneumatically-operated controllers with low emission alternatives. Shell recognizes that there remains uncertainty with measuring methane emissions. "This is an industry wide issue and we need to fix this fast," said Wetselaar. "We must get a much more accurate understanding of how much we are emitting."
SORL

Hot Stocks

06:08 EDT SORL Auto Parts selected for Longteng Program of China Custom - SORL Auto Parts announced it was selected by China Custom to enter into the Longteng Program. Started in 2017, the Longteng Program is the Chinese government's initiative to protect the intellectual properties of the leading Chinese companies against domestic Chinese copycats. China Custom leads the enforcement to oversee a wide array of products that have infringed intellectual properties and to stop them from shipping to international destinations. China Custom in Hangzhou has shortlisted 26 manufacturing companies ranging from home appliances to machinery for its submission into the Longteng Program. SORL is the only auto parts producer from the Wenzhou area selected by the Longteng Program. Since its inception, the Longteng Program has completed over 250 investigations and detained millions of illegal products.
GTHX

Hot Stocks

06:08 EDT G1 Therapeutics says expediting analyses of myelopreservation data - G1 Therapeutics announced that it is expediting analyses of myelopreservation data from its randomized Phase 2 trial of trilaciclib in combination with chemotherapy and Tecentriq in first-line small cell lung cancer. Myelopreservation results from the trial will be reported in the fourth quarter of 2018.
SNMX

Hot Stocks

06:07 EDT Senomyx to be acquired by Firmenich for $1.50 per share in cash - Firmenich and Senomyx announced that they have entered into a definitive merger agreement under which Firmenich will acquire all of the outstanding common stock of Senomyx for $1.50 per share in cash. This represents a premium of approximately 43% over Senomyx's closing price on September 14, 2018 and a premium of approximately 39% based on the prior 30-trading day volume-weighted average price. The proposed transaction has been unanimously approved by the Boards of Directors of both Firmenich and Senomyx. The companies expect to close the transaction in the fourth quarter of 2018. Upon closing, Senomyx will be integrated into Firmenich's North America Research & Development organization and its products will be commercialized through its Taste Platform. Senomyx R&D operations will remain in San Diego, with a continued focus on discovering and developing world-class flavor and sweetener solutions for the world's greatest brands. Under the terms of the merger agreement, Firmenich will promptly commence a tender offer to acquire all of the outstanding shares of Senomyx common stock for $1.50 per share in cash. Following the successful completion of the tender offer, Firmenich will acquire all remaining shares not tendered in the tender offer through a second-step merger at the same price as to be paid to stockholders tendering their shares in the tender offer. The tender offer is expected to expire at one minute following 11:59 p.m., Eastern Time, on the 20th business day after the launch of the tender offer, unless extended in accordance with the merger agreement and the applicable rules and regulations of the SEC.
PGNX

Hot Stocks

06:06 EDT Progenics says AZEDRA added to NCCN guidelines - Progenics announced that AZEDRA has been added to the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology for Neuroendocrine and Adrenal Tumors v 3.2018. NCCN Guidelines are widely recognized and used as the standard for clinical policy in oncology by clinicians and payors.
UTHR

Hot Stocks

06:06 EDT United Therapeutics enters licensing agreement with Samumed for IPF drug - Samumed has entered an exclusive license agreement with United Therapeutics for North American rights to Samumed's SM04646, being developed for the treatment of idiopathic pulmonary fibrosis, or IPF. Deal terms include $10M up-front, plus up to $340M in developmental milestones and up to low double-digit royalties. SM04646, a Wnt pathway inhibitor, is currently undergoing a phase 1 clinical trial. Under the terms of the agreement, United Therapeutics' subsidiary, Lung Biotechnology PBC, will conduct and fund all further development, regulatory and commercialization activities in the U.S. and Canada. Samumed retains development and commercialization rights for all markets outside of North America.
DWDP

Hot Stocks

06:05 EDT DowDuPont announces senior leadership for DowDuPont, Corteva Agriscience - DowDuPont announced the senior leaders of the independent companies that will be created following the separation of its Agriculture and Specialty Products Divisions, which is expected to occur by June 1, 2019. In addition, the company announced that Ed Breen, CEO of DowDuPont, will become executive chairman of DuPont following the separation. The senior leaders of Corteva Agriscience include: James C. Collins, Jr., currently chief operating officer of the Agriculture Division, will be chief executive officer; Greg Friedman, currently head of finance for the Agriculture Division and vice president, DuPont Investor Relations, will be executive vice president, chief financial officer; and Cornel Fuerer, currently head of legal for the Agriculture Division, will be senior vice president, general counsel. The senior leaders of DuPont include: Marc Doyle, currently chief operating officer of the Specialty Products Division, will be chief executive officer; Jeanmarie Desmond, currently head of finance for the Specialty Products Division and co-controller of DowDuPont, will be executive vice president, chief financial officer; and Erik Hoover, currently head of legal for the Specialty Products Division, chief compliance officer for DuPont, and assistant secretary for DowDuPont, will be senior vice president, general counsel. In his full-time role as executive chairman of DuPont, Mr. Breen will work closely with the senior leadership team and focus on the company's portfolio management strategy, capital allocation decisions, and, in conjunction with Marc Doyle, shareholder engagement. As CEO, Mr. Doyle will lead the organization and remain focused on business execution, growth initiatives, and further establishing a culture of innovation and operational discipline in order to maximize shareholder value. He will report to Mr. Breen.
SIR...

Hot Stocks

06:04 EDT Government Properties, Select Income REIT agree to merge - Government Properties Income Trust (GOV) and Select Income REIT (SIR) announced that they have entered a definitive agreement to merge which will create a real estate investment trust, or REIT, focused on owning, operating and leasing office buildings primarily leased to single tenants and high credit quality tenants like government entities. The surviving company in the merger will be GOV and it will change its name to Office Properties Income Trust, or OPI, upon closing the merger. OPI will continue to be managed by the operating subsidiary of The RMR Group (RMR). OPI will be listed on the Nasdaq and the ticker symbol "OPI" has been reserved for the company's common shares. The merger will be a stock for stock exchange whereby SIR shareholders will receive 1.04 shares of GOV for each common share of SIR based upon a fixed exchange ratio. Following the merger, GOV and SIR shareholders will own approximately 52% and 48% of OPI, respectively. As a condition of the merger, GOV will sell all 24.9 million of the common shares it owns in SIR. Also as a condition of the merger, after receiving shareholder approval for the merger and prior to its closing, SIR will distribute as a special dividend all 45 million of the common shares it owns in ILPT to SIR shareholders. ILPT is a REIT that is focused on owning warehouse distribution and e-commerce fulfillment facilities throughout the United States. These actions will eliminate the cross ownership among GOV, SIR and ILPT. SIR shareholders will receive approximately 0.502 shares of ILPT for every one share owned of SIR. Based upon closing prices on September 14, 2018, SIR shareholders will receive $11.69 per share from the ILPT share distribution and $17.57 per share in GOV for a total of $29.26 per share. OPI expects to pay an annual dividend between $0.50 and $0.60 per share, which is based upon a target dividend payout ratio of 75% of projected cash available for distribution. There is no plan to change the current dividend at GOV or SIR prior to closing. OPI expects to sell properties valued at up to $750 million to reduce leverage to a target debt to Adjusted EBITDA ratio of 6.0x to 6.5x within six months of the closing of the merger. The transaction is expected to close in late 2018 or early 2019, subject to customary closing conditions, including GOV and SIR shareholder approval.
GOV...

Hot Stocks

06:01 EDT Government Properties, Select Income REIT agree to merge
FB

Hot Stocks

06:00 EDT Facebook looking to hire Director of Human Rights Policy - Sara Su, Product Manager at Facebook, tweeted that the company is hiring a Director of Human Rights Policy "to drive investigations into abusers on our platforms, coordinate the company-wide effort on conflict prevention & peace-building, and advise product teams on making Facebook a positive force for human rights." Reference Link
KBR

Hot Stocks

05:59 EDT KBRwyle awarded contract by NASA - KBR announced that its global government services business, KBRwyle, has been awarded a contract to study the future of commercial enterprise in low-Earth orbit, or LEO, including long-range opportunities for the International Space Station, or ISS. NASA selected KBRwyle as one of thirteen contract awardees. KBRwyle will assess the potential growth of a LEO market and how to offer affordable access to LEO. It will also analyze how to foster demand for commercial and government use of LEO platforms and capabilities. KBRwyle will study specific industry concepts like the viability of habitable platforms including the space station and separate free-flying structures. According to NASA, the findings from these studies will help it, the administration and Congress develop a strategic approach to growing opportunities for American industry. The application of these results will expand access to LEO and stimulate a vibrant and competitive industrial base for continued U.S. leadership in space.
LNG

Hot Stocks

05:32 EDT Cheniere Energy, Vitol sign 15-year LNG sale, purchase agreement - Cheniere Energy announced that its subsidiary Cheniere Marketing has entered into a liquefied natural gas, or LNG, sale and purchase agreement, or SPA, with Vitol. Under the SPA, Vitol has agreed to purchase approximately 0.7 million tonnes per annum of LNG from Cheniere Marketing on a free on board basis for a term of approximately 15 years beginning in 2018. The purchase price for LNG is indexed to the monthly Henry Hub price, plus a fee.
AMZN

Hot Stocks

05:29 EDT Amazon announces new 'Amazon Storefronts' - Amazon opens "Amazon Storefronts," a new store for customers to shop exclusively from U.S. small and medium-sized businesses selling on Amazon. With Storefronts, customers can shop a curated collection of over one million products, and deals from nearly 20,000 U.S. small and medium-sized businesses, and learn more about profiled businesses through featured videos and stories. Amazon launched the new store to offer customers an easy way to buy from small and medium-sized businesses in all 50 states through the convenient and trusted Amazon experience. Amazon Storefronts features a variety of product categories including Back to School, Halloween, Home, Kitchen, Pet Supplies and Books. To support the launch of the new store, Amazon is unveiling its first-ever national TV commercial featuring real businesses that sell on Amazon. With more than a million small and medium-sized businesses in the U.S. selling on Amazon, the ad gives customers a glimpse into a real business on Amazon and how Amazon is actually a 'Big collection of Small.' The commercial shows how Amazon helps businesses get their products to customers all over the world. To help illustrate the growing number of businesses on Amazon, a series of business logos come together at the end of the ad to form the Amazon smile logo.
NXPI

Hot Stocks

05:26 EDT NXP Semiconductors, Hitachi Solutions collaborate on V2X solution in Japan - NXP Semiconductors and Hitachi Solutions have announced a partnership to develop a new V2X solution targeted at the Japanese market. The solution will employ an NXP developed V2X modem and processor and a full Hitachi Solutions V2X software stack, providing automakers that target the Japanese market with a head start in the development of their own V2X solutions, whether they are on board units or full Telematics Modules. The solution's ability to address 5.9GHz and 760MHz V2X implementations means that other markets, such as those in Europe and the United States, could be addressed with a single, reusable design, offering savings in automotive development costs. As part of the cooperation with Hitachi Solutions, NXP will implement the SAF5400, the world's first automotive qualified, high-performance single-chip DSRC modem that also supports Japan. Its unique scalable architecture, industry leading features such as fast startup time, long range, dual digital antenna diversity and leading-edge Software Defined Radio technologies offer car makers flexible options for global V2X adoption and field upgradeability. SAF5400 is the 2nd generation of the only global V2X solution and has been proven on the road since 2017. The NXP and Hitachi Solutions V2X solution will be available in Japan by 2019 and additional markets of Europe and North America soon after. Hitachi Solutions will support all layers above the SAF5400 firmware including network, facilities and application. NXP and Hitachi Solutions will offer strong Japan-based technical support as well as corresponding support in North America and Europe after additional rollouts.
QGEN

Hot Stocks

05:19 EDT Qiagen, NeuMoDx Molecular announce strategic partnership - Qiagen and NeuMoDx Molecular announced a strategic partnership to commercialize two new fully integrated systems for automation of polymerase chain reaction, or PCR, testing. These next-generation systems are specifically designed to help clinical molecular diagnostic laboratories process increasing test volumes and deliver more rapid insights on a broad range of diseases. Under the agreement, Qiagen will initially distribute the NeuMoDx 288 and NeuMoDx 96 in Europe and other major markets worldwide outside of the United States. NeuMoDx will cover the United States directly. Additionally, the companies are collaborating to implement certain Qiagen chemistries on the NeuMoDx systems. The two companies have also entered into a merger agreement under which Qiagen can acquire all NeuMoDx shares not currently owned by Qiagen at a predetermined price of approximately $234M, Qiagen currently owns about 19.9% of NeuMoDx, subject to the achievement of certain regulatory and operational milestones. Qiagen intends to begin commercialization of the NeuMoDx systems at the European Society of Clinical Virology congress with an initial assay menu based on the first two CE-IVD marked assays for Group B Streptococcus and Chlamydia trachomatis/Neisseria gonorrhoeae infections. The NeuMoDx systems offer a growing menu of relevant in vitro diagnostic, or IVD, tests and the ability to process both commercial and laboratory-developed tests in the most flexible and efficient manner. LDTs, which account for an important number of test requests and volumes, are IVD tests designed by clinical labs for their own use.